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CHAPTER I
STATEMENT OF THE PROBLEM
Introduction
Menopause is a natural biological event in the reproductive cycle of
women usually experienced around their 50th birthday (MacPherson, 1981 ).
It has been defined as the last menstruation in a woman's life (WHO, 1981 ).
Menopause signals the end of a woman's reproductive ability and is
accompanied by profound hormonal changes (Upton, 1982).
Menopause has long been viewed as the onset of "the change", a lay
term for menopause, for a midlife woman. In actuality, menopause may only
signal the end of "the change" rather than the beginning, since many changes,
physical, psychological, and physiological, occur years before the actual
menopause, that is, during the perimenopausal period.
Perimenopause is a process of gradual depletion of ovarian follicles
leading to eventual cessation of ovarian function (Richardson & Nelson, 1994).
Over the last few years, perimenopause has been increasingly recognized as not
only a separate entity but also as more important than the actual menopausal
or postmenopausal period. Many physical symptoms such as hot flashes and
night sweats and/or psychosomatic symptoms such as depression, irritability,
headache and sleep disturbance may occur more frequently at this time.
It is estimated

that there

are currently

more than

13

million
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perimenopausal women in the United States. By the year 2000, there will be
about 19 million women going through this perimenopausal transition
(Bachmann, 1994a). Evidence exists that a third to one half of midlife women
are affected by perimenopausal symptoms (McKinlay, Brambilla, & Posner,
1992). With the increasing number of perimenopausal women in the United
States, prevention and management of perimenopausal symptoms for midlife
women becomes critical and must be emphasized.
Traditional treatment for symptoms associated with perimenopause has
been the administration of estrogens, either alone or in combination with
progestin. However, hormone replacement therapy (HRT) is not without risk.
Well-designed studies have demonstrated there is a significant linkage between
estrogen and endometrial cancer. In addition, it has been reported that there
was a 10% added risk of breast cancer among postmenopausal women who
took estrogen for an average of 5. 7 years, a risk that was slightly increased
with the addition of progestin (Wilbur, Dan, Hedricks, & Holm, 1990).
Although the general consensus is that the benefits outweigh the risks, the
concern remains.
The evaluation of alternatives to estrogen therapy for symptom control
during perimenopause is receiving increased attention. It is known that regular
physical activity is beneficial in lessening a number of physical and mental
s;ymptoms. Thus it is reasonable to ask whether physical activity will impact
on symptoms associated with perimenopause as well. Further, the idea of a
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protective effect of long term patterns of physical activity on perimenopausal
symptoms is also plausible with precedence established for the beneficial
effects of long term physical activity on coronary heart disease, hypertension,
diabetes mellitus, and breast cancer (Pate et al., 1 995).
Thus, physical activity may be one of the most promising alternatives to
hormone therapy. However, to date the literature has been sparse concerning
the relationships between symptom control at perimenopause and physical
activity. Thus, the purpose of this study was to determine the relationships
between physical activity and symptoms in perimenopausal women.
Significance of the Study
The information obtained from this study will contribute to the growing
body of knowledge on determining the effectiveness of physical activity, an
intervention that presents with minimal health risk, on symptoms associated
with perimenopause.

Nurses as well as physicians can become more

knowledgeable regarding the effect of physical activity on perimenopausal
symptoms. Nurses can play a significant role in encouraging, supporting, and
teaching perimenopausal women to engage in regular physical activities. The
development of regular physical activity habits in young girls and women of all
ages could be an alternative and/or complementary solution for preventing and
reducing perimenopausal symptoms.

The introduction of physical activity

regimens and the support of women engaged in regular physical activities could
reduce human suffering from perimenopausal symptoms and enhance quality
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of life of midlife women.

CHAPTER II
REVIEW OF THE LITERATURE
Evolution of Definitions of Perimenopause
Perimenopause has long been incorporated into the concept of
menopause. In fact, perimenopause still is not listed in the Cumulated Index
Medicus as a separate subject heading. Therefore, in order to understand the
concept of perimenopause, the concept of menopause needs to be analyzed
first.
Literally, the term menopause is defined as a permanent cessation of
menstruation resulting from loss of ovarian activity (WHO, 1981). It is a single
point in time, the last menstruation. For the sake of accuracy, the diagnosis
of menopause is made retrospectively after complete cessation of menses for
a period of one year.
Menopause can be natural, premature or artificial. Natural menopause
is the spontaneous cessation of menses after the age of 40 years usually
occurring around the age of 50 years (MacPherson, 1981).

Spontaneous

cessation of menses before the age of 40 years is called premature menopause
or premature ovarian failure.

For the premature menopausal women, the

perimenopausal symptoms can occur as early as a few years after menarche
(Vada & George, 1986).

The etiology for premature ovarian failure is not

5
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known. Surgical or artificial menopause is defined as cessation of menstruation
due to surgical removal of the uterus, ovaries, or both, with or without the use
of hormone replacement therapy.
A review of literature on menopause indicated that confusion exists
regarding the definition of menopause. Menopause has been used in several
ways: 1) as the end-point of reproductive life, that is, the last menstruation
(WHO, 1981 ); 2) as a period of time before and after menopause (Hunter,
1992); 3) as a period of time after menopause (MacPherson, 1981 ); and 4) as
a time frame which includes the entire menopausal process of pre-, peri-, and
postmenopausal period (Budoff & Sommers, 1979). Using different definitions
of menopause results in a lack of conceptual clarity and methodological issues
such as the inability to compare research findings across studies but also fails
to recognize the distinctions between the different stages of the menopausal
experience.
Several terms have been used synonymously with menopause. One of
these terms is the "change of life" which is no longer accepted by modern
women. Another term used by researchers is climacteric which is defined as
a transition from reproductive to nonreproductive life (Uphold & Sussman,
1981 ). However, the latter concept has been used in an ambiguous manner and
most researchers have found the term climacteric too vague to be useful. For
example, the term climacteric refers to a time span of 5 to 25 years and its
onset and duration is uncertain. Some researchers define it as extending well
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into the postmenopausal years (Harper, 1990).
Definitional issues related to menopause were addressed at the First
International Congress on Menopause.

In that meeting, menopause was

defined as "the final menstrual period and occurs during the climacteric" (Utian,
1980, p.3). It would seem that using the cessation of menses as a criterion to
define menopause might have the advantage of providing a relatively objective,
reliably determined and clearly marked distinction between the pre- and postmenopausal women (Kaufert, 1986). However, this definition gives the faulty
impression that there is an abrupt change in ovarian function (i.e. ovarian
function is normal one day and ceases functioning the next day). Furthermore,
including all premenopausal women in one category fails to discriminate
between women who are menstruating regularly and those who have menstrual
cycles that become increasingly irregular as they approach menopause. Thus,
a new concept was needed to represent women who are approaching
menopause.
In 1967, Treloar, Boynton, Behn, and Brown introduced the concept of
perimenopause. They indicated that the critical marker of perimenopause was
menstrual irregularity, defined as genital bleeding changing to either longer or
shorter than its usual flow intervals.
Based on these ideas, the three-stage definition of menopausal status
was introduced by Jaszmann, van Lith, and Zaat ( 1969). Their definition of
menopause status was as follows:
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"Premenopause:

Women who had normal menses for the past year;

Menopausal: Women reporting a menstrual pattern different from the
former pattern, i.e., those who had more or fewer menstrual flows than
previously over the past year; Postmenopause:

Women who did not

menstruate in the past year" (p. 269).
In this article, the period of change in menstrual pattern was recognized as a
distinct stage, although the stage was termed menopausal rather than
perimenopause.

This study marked the emergence of the concept of

perimenopause.
The definitions of perimenopause along with the definitions of
menopausal status were modified by the World Health Organization's (WHO)
technical report ( 1981), "Research on Menopause". The following definitions
were given:
"Menopause: the permanent cessation of menstruation resulting from
loss of ovarian, follicular activity; Perimenopause (or climacteric): the
period immediately prior to menopause when endocrinological, biological,
and clinical features of approaching menopause commence, continuing
for at least the first year after the menopause; Postmenopause: a period
dating from menopause, although it cannot be determined until after 12
months of spontaneous amenorrhea; Premenopause: the whole of the
reproductive period prior to menopause" (p. 8).
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Although WHO' s ( 1 981 ) definition of perimenopause was clear, its
definition of premenopause was still ambiguous.

The premenopausal and

perimenopausal phases were not mutually exclusive.

The definition of

premenopause still included women who had entered the perimenopausal
phase. Many researchers still found the definition too confusing to be useful.
The three-stage definition of menopause status was further developed
and modified (Kaufert et al., 1986) based on the previous works of Treloar et
al. ( 1967) and Jaszmann et al. ( 1969) and the assumption of hormonal change.
Women who reported no change in menstrual flow or frequency during the last
1 2 months were defined as pre-menopausal. The underlying assumption is that
menstrual pattern stability reflects hormonal stability. Women who reported no
menses

for

twelve

consecutive

months

or

longer

were

defined

as

postmenopausal. The assumption is that after 1 2 months of amenorrhea, it is
certain that ovulation has ceased and that hormonal levels within the ovary
have stabilized at the postmenopausal level. Women who reported changes in
menstrual flow or frequency during the last 1 2 months are categorized as
perimenopausal. The basic assumption underlying perimenopause is that
changes in menstrual pattern signify that menopause is inevitable (Kaufert et
al., 1986). Therefore, perimenopause is defined as changes in menstrual flow
or frequency or no menses for three to eleven months.
The standard three-stage definition of menopausal status given by
Kaufert et al., 1986 is useful because it recognizes the differences in
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experience between pre-, peri- and postmenopausal women.

In addition,

researchers could use the same criterion to define status, and comparisons
could be made between different study populations.
Based

on

the

three-stage

definitions

of

menopausal

status,

perimenopause is generally a period of a few years before and one year after
the menopause. It starts when the active ovary begins to fail and ends with the
final lapse of the ovary into inactivity. During this period maximal reproductive
hormone fluctuation occurs prior to the final menses (Kaufert, 1986).

It is

characterized endocrinologically by evidence of decreasing ovarian activity,
biologically by decreasing fertility, and clinically by alteration in menstrual cycle
intervals and maybe by a variety of symptoms (Upton, 1982). However, the
criteria used to define perimenopause in clinical research generally include only
changes in menstrual flow and/or regularity indicated by unusually long or short
menstrual cycles, diminished menstrual flow, or intermittent menstrual cycles
that terminate in menopause (Feldman, Voda, & Gronseth, 1985).

The

biological and endocrinological parameters are often not included because 1)
measuring the hormone levels requires drawing blood and ordering lab tests
which are inconvenient and costly and 2) it is inappropriate to determine a
woman's fertility only for the purpose of menopausal research.
In the perimenopausal literature, however, not all authors have used the
standard three-stage definitions of perimenopause as described above. Some
investigators loosely and inaccurately defined perimenopause as a period of
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time around menopause (Cutick, 1984). Perimenopause has been used to refer
to different age groups. For example, it was used to describe women 35 to 50
years of age (Feldman, Voda, & Gronseth, 1985) or 25 to 74 years of age
(VanHall, Vardel, & Velden, 1994). These studies used subjects with an age
range of 1 5 years or more and considered these women as perimenopausal.
Apparently women who were clearly "premenopausal and postmenopausal"
were included in the perimenopausal category.
Several other definitions of perimenopause have been used.

First,

perimenopause has been defined as an indefinite period of time that begins with
the onset of the first hot flash and terminates when hot flashes disappear
(Voda, 1984). This definition implies that perimenopause is not experienced
by women who do not have hot flashes; women who do have hot flashes may
experience them many years before menopause as well as many years after
menopause.

Although this definition provides an objective indicator of the

onset and duration of perimenopause, it has little empirical value in terms of
categorizing women, since not every woman has hot flashes during the
menopausal process

and

not every woman

who

has hot flashes

is

perimenopausal.
Finally, perimenopause has also been defined as a period which includes
all three stages of menopause (Harper,

1990), thus the duration of

perimenopause would be about 25 years (women aged 35-60). Obviously, this
definition, including all menopausal women in the same group, fails to
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demonstrate the difference in menopause experienced between the different
stages of menopausal women.
In summary, for the purpose of this study, perimenopause is defined as
a few years before the actual menopause is diagnosed.

It is primarily

operationalized as the changes in menstrual pattern which includes menstrual
cycle and/or flow irregularity and/or no menstruation for more than three and
less than 12 months (Figure 1) in the past year.

Since women who have a

premature or surgical menopause have an atypical perimenopause experience,
this study only focuses on natural perimenopause.
Hormonal Aspects of Perimenopause
Several studies (Hee, MacNaughton, Bangah, & Burger, 1993; Longcope,
Franz, Morello, Baker, & Johnston, 1986; Richardson, Senikas, & Nelson,
1987; Shideler, DeVane, Kalra, Benirchke, & Lasley, 1989; Trevoux, Brux,
Castanier, Nahoul, Soule, & Scholler, 1986) have been conducted to describe
the endocrine characteristics of menstrual cycles in perimenopausal women.
Information was obtained from both cross-sectional and longitudinal data.
Hormonal profiles of perimenopausal women are characterized by a great
deal of variability and lack of predictability.

According to Richardson and

Nelson ( 1994), the human ovary steadily loses follicles from mid-fetal life. The
number of follicles remaining in the mature ovary is the major determinant of
the timing of both perimenopause and menopause. In a study of follicle number
in ovaries in 17 healthy women aged 45 to 55 years, Richardson, Senikas, &

Figure 1. The perimenopausal period
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Nelson ( 1 987) found that the mean number of primordial follicles in the ovaries
of women who were still menstruating regularly was ten-fold greater than in the
ovaries of perimenopausal women of the same age. Follicles were fewer or
absent from the ovaries of the postmenopausal women. They concluded that
the size of the follicular reserve was the major determinant of both the
transition from regular menses to the perimenopause as well as to the
menopause itself (see Appendix A).
With the decreased level of ovarian follicles in perimenopause, the
secretion of estrogen is greatly diminished (Hee et al., 1993; Longcope et al.,
1986;

Shideler et al.,

1989;

and

Trevoux

et

al.,

1986)

(Table

1).

Perimenopausal women have low levels of estrogen and progesterone that are
midway between the normal reproductive range and the postmenopausal range
(Hee et al., 1993).

Estradiol remains the major form of estrogen during

perimenopause. There is a great deal of day to day fluctuation in this hormone
level. During the postmenopausal period, the major source of estrogen comes
from the peripheral conversion of estrone and testosterone. Compared to preand perimenopausal women, postmenopausal estrone levels are higher than
estradiol levels (Greendale & Judd, 1993).
Further, with decreased ovarian follicles, the follicle stimulating hormone
(FSH)

level

becomes elevated

as a compensatory

mechanism in the

perimenopausal period and remains elevated within the range defined as
postmenopausal (Longcope et al., 1986). Luteal hormone (LH) level can be
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elevated or remain in the normal range (Cook, 1993).
The perimenopausal cycle can be ovulatory or anovulatory.

The

ovulatory cycle is characterized by a midcycle estrogen surge and subsequent
luteal phase progesterone secretion that is lower than that found in the normal
reproductive cycle, while the anovulatory cycle is characterized by a rise and
fall in estrogen levels and no progesterone secretion (Upton, 1982).
Clinically, perimenopausal women usually have either a shorter or longer
menstrual cycle compared to premenopausal women.

Short cycles are

accompanied by shorter follicular phases (6-10 days in length) and a normal
duration of luteal phase. The longer menstrual cycles are usually anovulatory
and last 40 to 60 days. Furthermore, the menstrual cycles in perimenopausal
women are irregular and unpredictable and can have a duration varying from 20
to more than 60 days (Shermen, West, & Korenman, 1976).
Methodological issues, however, have to be considered when interpreting
data. Gonadotrophins are secreted episodically, yet some studies obtained
individual blood samples at isolated time points (Longcope et al., 1986). These
samples could have been obtained anywhere during or after a secretory
episode. Therefore, bias due to timing or frequency of sampling might have
occurred. Additionally, some studies used small sample sizes. For example,
Shideler et al. ( 1 989) in their study used only two perimenopausal subjects;
Hee et al. ( 1993) used three; and Richardson et al. ( 1987) used seven.
Therefore, generalization of findings from these studies is difficult.
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In summary, measuring the hormonal level may be a more objective way
of defining menopausal status, but the cost and time frame for a doctoral study
prohibited this approach for this study. In addition, menstrual cycle change
during perimenopause closely reflects the hormonal change. Therefore, again,
changes in menstrual patterns were used to define perimenopause in this study.
Clinical Aspects of Perimenopause
Age and Duration of Perimenopause
The onset and the duration of perimenopause have not been widely
studied. Only three studies were found which dealt with the age at onset and
the duration of the perimenopause (see Appendix 8).

In a survey of 6877

women aged 38 to 58 years, Magursky, Mesko, and Sokolik ( 1975) found that
the age at onset of the perimenopause was approximately 47.5 years. In this
study, the term climacteric was used to mean perimenopause.

These

investigators noted that onsets of perimenopause and menopause were related
to menstrual disturbance and occupation.

Women with more menstrual

disturbances had their menopause about one year earlier than other women.
Women who were manual workers and those in occupations other than
housewives and agricultural workers had their menopause and onset of
perimenopause at least a year earlier. Age at menarche and parity was not
associated with the age at the onset of perimenopause.
Treloar ( 1 981), in a study of 291 women who were followed from the
time of menarche to natural menopause, found that the median age for the
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onset of perimenopause was 45.5 years, with a range of 34 to 55 years. The
duration of perimenopause was 4.8 years (median value) with a range of one
to 10 years. He also found a long perimenopause usually began with a slow
increase in cyclic variations which were linked to duration of perimenopause.
More than a decade later, McKinlay, Brambilla and Posner (1992)
conducted a large and comprehensive prospective cohort study of 2500 midaged women. Their results were strikingly similar to Magursky and colleagues'
study in 1975. McKinlay et al. found that the onset of perimenopause was
4 7. 5 years and the duration was about 4 years. They noted that there were
several factors such as smoking that affected the onset and duration of
perimenopause. Smokers tended to have not only an earlier, but also a shorter
perimenopause.
The discrepancies in age of inception of perimenopause noted in the
above studies may be explained by the differing samples. Studies conducted
by Magursky et al. ( 1975) and McKinlay et al. ( 1992) used women with more
limited age ranges than Treloar's study (1981 ). Therefore, women with early
perimenopause and menopause may not be represented in their samples.
Conversely, Treloar' s ( 1981) study may have included women with premature
menopause.
In summary, age is an important factor in the onset of perimenopause.
Most women will begin their perimenopause at about age 45 to 4 7 years.
However, a few women may experience perimenopause as early as their late
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30s and as late as their middle 50s. Perimenopause lasts one to ten years with
an average of four years.

In this study, women who have changes in their

menstrual pattern and are aged 40 years and above are evaluated to exclude
women who might experience premature menopause.
Symptoms of Perimenopause
A number of studies have reported on the incidence of symptoms
reported by perimenopausal women (Seltzer, Benjamin & Doutsch, 1990;
McKinlay et al., 1992; Holte, 1992; Dennerstein et al., 1993). A comparison
of the findings of these studies is, however, limited by methodological issues.
For example, some studies recruited women attending clinics as subjects
(Seltzer et al., 1990) and others used nonclinical population samples (McKinlay
et al., 1992).

In addition, some studies failed to distinguish between

perimenopausal

and

postmenopausal

or

between

premenopausal

and

perimenopausal phases.
Menstrual changes
The first sign of perimenopause is a change in menstrual bleeding. The
literature has consistently reported menstrual irregularity with either scanty or
profuse bleeding during perimenopause (Bachmann, 1994b). It is believed that
menstrual irregularity reflects marked fluctuations in levels of estrogen and
progesterone or outright deficiency.

Clinical studies of menopausal women

have shown that approximately 90% of women will experience menstrual
irregularity during perimenopausal years; only 10 to 12% of premenopausal
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women will have sudden amenorrhea (McKinlay et al., 1992; Seltzer et al.,
1 990; Treloar et al., 1967). For example, a classic extensive longitudinal study
of menstrual intervals throughout life by Treloar et al. ( 1967) found that
beginning seven years before menopause, the incidence of short and long
cycles dramatically increased and reached its peak about 4 years before
menopause.

During this time, the mean variability of menstrual intervals in

individual women also increased.

Further, Seltzer et al. ( 1 990), in a chart

review study of 500 perimenopausal patients reporting alterations in menstrual
flow, found 86. 7 % of perimenopausal women with irregular menstrual
bleeding have oligomenorrhea, or abnormal menstrual periods (intervals of 36
to 90 days between periods) or hypomenorrhea (regular menses but decreased
in amount); and 13.3% report menorrhagia, metrorraghia, and hypermenorrhea
(see Table 1 ). However, caution has to be taken when interpreting this study
because the study was retrospective and data were obtained by chart reviews
of the clinical population. Thus, the incidence of menstrual problems may not
be representative of the general population.
Abnormal bleeding can be disturbing, especially if it's heavy and
unpredictable.

McKinlay and colleagues ( 1992) indicated that irregular

menstrual bleeding during perimenopause appears to be more worrisome to
women than hot flashes, particularly if this irregular menstrual bleeding persists
beyond a year or two.

While clinical papers emphasize menstrual problems

during perimenopause (Bachmann, 1994a), such menstrual problems did not
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stand out as a significant symptom in research studies.

This may reflect

researchers' bias in the measurement of symptoms during perimenopause.
Either menstrual problems were not included in the measurement tool or were
not analyzed as separate symptoms. Consequently, menstrual problems may
not have been evident because they were grouped into the "other" categories.
In this study, prevalence of menstrual changes measured by several items and
the effect of long term physical activity on menstrual changes were evaluated.
Table 1.
Examples of menstrual irregularity during perimenopause

Type of menstrual irregularity

Definition

Oligomenorrhea

Scanty or infrequent menstrual flow

Abnormal menstrual periods

Irregular menstrual flow

Hypomenorrhea

Deficient amount of menstrual flow
but periods are regular

Menorrhagia

Excessive bleeding at the time of a
menstrual period, either in number of
days or amount of blood or both

Metrorraghia

Bleeding from the uterus, esp. at any
time other than during the menstrual
period

Vasomotor symptoms
Although some years ago researchers believed that most menopausal
symptoms started with the onset of menopause, current data suggest that
vasomotor symptoms, psychosomatic symptoms and sexual problems may
begin during the pre- and perimenopausal period. All studies reviewed, both
cross-sectional and longitudinal, demonstrated a marked and significant
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increase in vasomotor symptoms such as hot flashes and night sweats, during
the perimenopausal period (Avis, Kaufert, Lock, McKinlay, & Vass, 1993;
Ballinger, 1985; Dennerstein et al., 1993; Hunter, 1992; McKinlay et al., 1992)
(see Appendix C); and all studies reviewed found a significant relationship
between vasomotor symptoms and menopausal status (see Appendix D).
Hot flashes have been described by women as strong sensations of
warmth, skin irritation, and perspiration that travel from the trunk toward the
head before spontaneously disappearing. Hot flashes may be spontaneous,
uncomfortable, and unpredictable, and may occur any time of the day or night.
Episodes may last from seconds to minutes and occur frequently with varying
intensity (Feldman et al., 1985). Hot flashes are often temporary but may last
one to five years.
Estimates of prevalence of hot flashes in population studies ranged from
31-50% depending on the geographic region (Avis et al., 1993; Hunter, 1992;
Jaszmann et al., 1969; McKinlay et al., 1992). Discrepancies in prevalence of
vasomotor symptoms reported in epidemiologic surveys probably reflect
inconsistencies in research methodologies. For example, the different methods
of data collection may have influenced responses. A mailed questionnaire was
used as a mode of data collection in Avis and colleagues' study (1993), while
a combination of telephone interview and postal questionnaire methods were
used in McKinlay and colleagues' study (1992). Interview as a method of data
collection may increase the accuracy of data, yet interviewer-bias may also be
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manifested.
Vasomotor symptoms are not unique to perimenopause; they occur
throughout the reproductive years.

However, the majority of studies (see

Appendix C) reviewed found occurrence of vasomotor symptoms to peak during
perimenopause.

For example, MacKinlay and colleagues ( 1992) conducted

probably the largest and most comprehensive prospective cohort study of
middle-aged women, the Massachusetts Women's Health Study (MWHS).
They studied 1178 women between the ages of 45 to 55 years.

This

prospective study consisted of six telephone contacts at nine-month intervals.
They reported that hot flashes were experienced in only 10% of premenopausal
women.

This incidence rate increased slowly before the transition to

perimenopause,

then increased rapidly during perimenopause to a peak of

about 50% during the last year of perimenopause (the year just after the
cessation of menses). Then the rate began to decrease. At four years after the
last menstrual period, the rate of hot flashes had declined to 20%.
Vasomotor symptoms have strong associations with other symptoms
presumably associated with perimenopause such as cold sweats, insomnia,
fatigue, nervousness, and depression (Utian, 1980). The majority of women
who reported experiencing hot flashes also reported cold sweats.

Insomnia

was more likely to be reported by women who experienced hot flashes. This
phenomenon may be due to sleep disturbance from frequent episodes of hot
flashes and cold sweats during the night (Hunter, 1992; MacKinlay et al.,
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1992).
Attempts have been made to identify the factors that might predi.ct
women experiencing vasomotor symptoms.

Length of perimenopause was

found to be related to the occurrence of vasomotor symptoms (McKinlay et al.,
1992). Women with shorter or no perimenopause were less likely to have hot
flashes than women with a longer perimenopause.

The differences in

percentage of incidence of vasomotor symptoms between women with average
length of perimenopause and those with short or no perimenopause phase was
12%. Women with a longer perimenopause were also likely to have menstrual
problems (McKinlay et al., 1992).
A history of premenstrual tension and/or having vasomotor symptoms
when menstruating regularly before perimenopause has been correlated with
vasomotor symptoms during perimenopause (Hunter, 1 990). The author gave
three explanations.

First, there may be some type of hormonal pattern

predisposing women to both kinds of symptoms.

Second, vasomotor

symptoms may be an illness behavior. Some people complain more about a
whole host of symptoms because they are more preoccupied by bodily
changes. Finally, women with a history of menstrual problems may develop
learned reactions to reproductive changes.
In summary, consensus has been reached

that there is a significant

relationship between vasomotor symptoms and menopausal status.

In this

study, occurrence and distress associated with vasomotor symptoms and
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impact of long term physical activity on vasomotor symptoms were examined.
Psychosomatic symptoms
Historically a variety of psychosomatic complaints, such as clinical
depression, anxiety or irritability, depressed mood, feeling blue, fatigue,
palpitations, headache, and insomnia have been attributed to perimenopause,
since these symptoms seem slightly increased during this period (Holte, 1992).
It has been reported that perimenopausal women had significantly higher levels
of psychologic distress and more psychosomatic symptoms than pre- and
postmenopausal women (Dennerstein et al., 1993; Stewart, Boydell, Derzko,
and Marshall, 1992).

For example, Stewart, Boydell, Derzko, and Marshall

( 1 992), in a study of psychological distress in peri- and postmenopausal women
(peri-, n = 113 and postmenopause, n = 146) attending a menopause clinic,
found that perimenopausal women had significantly higher levels of psychologic
distress. Furthermore, Dennerstein et al. ( 1993), in a study of 2000 women
aged 45-55 years, found that premenopausal women were the least
symptomatic and perimenopausal women the most symptomatic. Vasomotor
symptoms and general psychosomatic symptoms were more frequent in the
perimenopause.
Psychosomatic symptoms during the entire menopausal period include
depression, fatigue, irritability, sleep disturbance, and mood change. In general,
the incidence of psychosomatic symptoms is higher in perimenopausal than in
premenopausal women,

yet the degree of difference

in incidence of
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psychosomatic symptoms is much lower than that of vasomotor symptoms.
Furthermore, whether the increase in psychosomatic symptoms during midlife
is associated with perimenopause and menopause remains unanswered.
In the last decade, a number of cross-sectional studies of midlife women
have been conducted to study the relationship between psychosomatic
symptoms and menopausal status.

The few conflicting results such as the

relationship between menopausal status and depression may be explained by
methodological problems, for example, the confounding effects of age, and the
use of different lists of menopausal symptoms and different definitions of
psychosomatic symptoms. In addition, strongly held beliefs and expectations
regarding

menopause

are

likely

to

influence

women's

responses

to

questionnaires if they are aware that menopause is being investigated.
In the past five years, several prospective studies have examined the
relationship between psychosomatic symptoms and menopausal status (Holte,
1992; Hunter, 1990; McKinlay et al., 1992).

Strengths of these studies

include the use of the standard three-stage definition of menopausal status, and
following women for several years so that the data represent the entire
perimenopausal period.
Although the majority of the longitudinal studies did not find a significant
relationship between psychosomatic symptoms, for example, depression, and
menopausal status, one investigator (Hunter et al., 1986; Hunter, 1992) found
that depression was significantly related to menopause. The conflicting results
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may well be explained by the different definitions and measurements of
depression used in various studies. While Hunter ( 1 992) viewed depression as
depressed mood and feeling blue, Kaufert et al. ( 1 988) focused on measuring
depressive symptoms more than mood change. Therefore, it seems likely that
the use of different operational definitions of depression contributes to
equivocal findings. There seems to be a trend that depressed mood is related
to perimenopause, while depressive symptoms and clinical depression are not
(Ballinger, 1990). In the current study, depressed mood and psychosomatic
symptoms such as headache, nervousness, and their relationship to regular
physical activity were evaluated.
Disturbances of sexuality
Although the disturbance of sexuality may be more of a problem for
postmenopausal women, it may also occur in perimenopausal women.
Depending on the demographics of the population studied, the definition used
for sexual disturbance and on the particular sexual behavior reported, studies
evaluating sexual function in midlife women found that the incidence of sexual
disturbances ranged from 5 to 85% (Davidsen, 1985; Hallstrom, 1973; Hunter,
1992; Koster & Davidsen, 1993). The determinants of sexual behavior are
thought to be complex and interrelated.

According to Greendale and Judd

( 1993), sexual function is regulated by three general components: "the
individual motivation (also called desire or libido), endocrine competence, and
social-cultural beliefs" (p. 429).
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Women attending clinics with perimenopausal complaints commonly
report vaginal dryness and associated dyspareunia (Davidsen, 1985; Hunter,
1 992).

It is generally agreed that vaginal dryness is associated with low

estrogen levels during perimenopause (Hunter, 1993). Vaginal dryness may
affect sexual functioning and possibly lead to a decline in sexual enjoyment and
interest. According to Bachmann ( 1994), during perimenopause, women often
report a decrease in sexual desire and a diminished amount of vaginal
lubrication with sexual arousal and coitus. Inadequate vaginal lubrication may
lead to insertional dyspareunia. Similarly, Koster & Davidsen ( 1993) found that
30% of women experienced a decrease in sexual desire. Bachmann ( 1994)
reported that there was a gradual decline in sexual arousal and a progressive
decrease in coital frequency starting early in perimenopause.
A few available studies have found that decrease in sexual desire was
not related to menopausal status (Hunter, 1992; Koster & Davidsen, 1993). In
contrast, the change in sexual desire was highly correlated to previous and
· present subjective health status, former sexual activity, partner availability and
social status, and women's subjective assessment of being perimenopausal.
In the current study, the sexuality of perimenopausal women was examined .
./ In

summary,

many questions remain

unanswered

regarding the

perimenopausal experience. It is significant to note that not all perimenopausal
women experience symptoms around menopause. Therefore, it is important to
identify factors that influence the occurrence and intensity of perimenopausal
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symptoms. In the current study, the perimenopausal experience of long term
physically active women was described. In addition, whether regular physical
activity contributes to the improvement of perimenopausal experience was
evaluated.
Concept of Physical Activity
Physical activity as a health related behavior has been widely used and
studied.

Viewed as a behavior, physical activity has been defined as "any

bodily movement produced by skeletal muscles that results in energy
expenditure" (Caspersen, Powell, & Christenson, 1985). Exercise is a subtype
of physical activity. It is planned, structured and repetitive. In the literature,
physical activity and exercise has been used interchangeably.

Regular

moderate physical activity is an activity performed at least five times a week,
at an intensity of 3-6 METs (work metabolic rate/resting metabolic rate-the
equivalent of brisk walking at 3-4 mph for most healthy adults).

Recent

research suggested that it is a misperception of many people that to reap health
benefits they must engage in vigorous, continuous exercise.

Scientific

evidence clearly demonstrated that regular moderate-intensity physical activity
provides substantial health benefits. The current recommendation emphasizes
the benefits of moderate-intensity physical activity and of physical activity that
can be accumulated in relatively short bouts, such as five to 10 minutes of
brisk walking.

Existing evidence suggests that amount of activity is more

important than the specific manner in which the activity is performed. The
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health benefits of physical activity appear to accrue in approximate proportion
to the total amount of activity performed, measured as either caloric
expenditure or minutes of physical activity (Pate et al., 1995).

Therefore, in

this study, rather than measure the type of activities, the amount of activities
performed were measured.
Physical activity has been demonstrated to have optimal protective
effects against a number of chronic conditions, including stroke, coronary heart
disease (CHD), diabetes, osteoporosis, colon cancer and even breast cancer risk
(U.S. Congress, Office of Technology Assessment, 1992). Recently it was
proposed that physical activity may be beneficial to menopausal symptoms
(Gannon, 1988).

Although the empirical support for advocating physical

activity as a treatment alternative for menopausal symptoms is scarce, there
are theoretical justifications which warrant its serious consideration and
investigation.
Theoretical Speculations
The beneficial effects of physical activity on perimenopausal symptoms
may be achieved through several pathways.

Holders of the biomedical

perspective on menopause believe that symptoms around menopause are
caused by estrogen deficiency. However, recent research has posed serious
threats to this belief since prepubertal girls and women with primary
amenorrhea do not experience hot flashes (Rebar, 1987).

In addition, past

studies have not been able to find a significant correlation between hot flashes
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and plasma levels of estrogen (Ballinger, 1987; Hunter, 1988; Maddock, 1978;
Casper, Yen, & Wilkes, 1979).

In contrast, the absence of hot flashes is

notable in women with low estrogen levels. For example, Martin and colleagues
( 1 993) found that elevated FSH and lowered levels of estrogen were shown in
perimenopausal women without vasomotor symptoms. They concluded that
lack of symptoms during the perimenopausal transition was not attributable to
a difference in endocrinology.
Currently, it is proposed that hot flashes are caused by thermo regulatory
instability which is the result of a loss of ovarian function

and the

accompanying reduction in hypothalamic opioid tone (Greendale & Judd, 1993)
(see Figure 2).

Endogenous opioids regulate the major thermoregulatory

nucleus and the release of GnRH (hypothalamic gonadotropin releasing
hormone).

In premenopausal women, adequate levels of ovarian steroids

maintain the endorphin levels. However, with menopause and decreasing levels
of estrogen and progesterone, endogenous opioids may decrease and cease to
regulate GnRH and maintain thermal homeostasis. Evidence exists that there
is a significant reduction in endorphin levels in menopausal women (Petraglia
et al., 1985; Watts et al., 1985).

Therefore, a possible mechanism of the

effects of physical activity on perimenopausal symptoms is the release of
endogenous opiates, specifically, beta-endorphins.
Regular physical activity has been demonstrated to increase central
opioid activity, thus promoting thermal regulation. Research studies (McArthur,
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1985) have indicated that levels of beta-endorphins are increased after
exercise,

similar

to

how

estrogen

influences

vasomotor

symptoms.

Furthermore, people with higher levels of fitness have higher levels of base
beta-endorphins than people with lower levels of fitness. Thus it is plausible
that symptoms such as hot flashes can be minimized or alleviated by physical
activity.

Figure 2.
Theoretical speculations of physical activity on
perimenopausal symptoms

Physical activity

t

Beta-endorphins level

.t-

Psychological stress

Perimenopausal symptoms relief
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The second view of perimenopausal symptoms is that there is a link
between

psychological

stress

and/or

depression

experienced

befpre

perimenopause and the subsequent reporting of vasomotor symptoms (Hunter,
1 993). Hunter indicated that psychological symptoms can not be explained by
hot flashes, however, women who are distressed or under stress might be more
likely to

develop vasomotor

symptoms.

This

relationship

has been

demonstrated with both patients and the general population.

Gath and

colleagues ( 1987), in a cross-sectional survey of 500 middle-aged women,
found a significant association between psychiatric symptoms and hot flashes.
Hunter ( 1992), in a prospective study of 36 women, found women depressed
before perimenopause to be more likely to develop hot flashes three years later
when they entered perimenopause.
Ballinger and colleagues ( 1 979) proposed that the impact of life stresses
might actually lead to catecholamine and estrogen changes and hence
vasomotor symptoms. This theory was examined in a study of 10 clinically
depressed and 10 non-depressed menopausal women.

They found that

estrogen concentrations were lower in the depressed group. However, when
depression was lifted using anti-depressive drugs, the estrogen levels increased.
Physical activity may be useful in alleviating the perimenopausal
symptoms since physical activity can be stress-reducing. Physical activity as
an effective means of symptom relief through stress reduction has been
evaluated and proven in a variety of disorders (premenstrual disorder, tension
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depression){cite).

In addition, menopausal symptoms seem to respond

positively to stress reduction therapy. Studies (Germaine & Freedman, 1984;
Stevenson & Delprato, 1983) have shown that stress reduction methods such
as relaxation and self-control techniques are beneficial to hot flashes.
In summary, there are at least two possible pathways through which
physical activity effects perimenopausal symptoms. This study tested the
hypothesis that physical activity has a positive influence on perimenopausal
symptoms.
Research Studies of Relationship between Physical Activity and
Perimenopausal Symptoms
Physical activity as a treatment alternative for menopausal symptoms is
not a new idea. It has been advocated by health professionals for decades.
However, the majority of studies on physical activity as a therapeutic approach
in midlife women have primarily assessed the effects on bone aging and
cardiovascular degeneration, and rarely assessed for menopausal symptom
management (Gannon, 1988). Several anecdotal accounts have been published
which describe exercise as resulting in the alleviation of perimenopausal and
menopausal symptoms.

For example, Leven ( 1993), in a non-data based

article, suggests that regular moderate exercise can have a positive effect on
sexuality, although the relationship is not fully understood.

Exercise may

improve an individual's libido and overall sexual satisfaction.
A few empirical studies (Wallace, Lovell, Talano, Webb, & Hodson,
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1982; Hammar, Berg, and Lindgren 1990; Wilbur, Dan, Hedricks, & Holm,
1 992) in the literature have examined the relationship between physical activity
and menopausal symptoms (see Appendix E). Wallace and colleagues ( 1982),
in a study of pre- and postmenopausal women before and after an aerobic
conditioning program, found that postmenopausal women experienced a
reduction in vasomotor symptoms and that estrogen levels increased in both
pre- and postmenopausal women after the conditioning program.

The

weakness of this study was that it evaluated the short-term effects of an
exercise session or program without controlling subjects' prior fitness levels
which would have an impact on the physiological, psychological, and behavioral
effects of exercise. Small sample size may also undermine the study result.
Wilbur et al., (1992) in a study of 279 midlife women, found a
significant positive relationship between occupational energy expenditure and
vasomotor symptoms and general health.

However, there was a negative

correlation between leisure time physical activity (as measured by energy
expenditure) and overall symptom reporting. The problem with this study was
that it used women from the general population. These women may not have
been physically active at all.

Therefore, the sample may not have been

adequate to test the relationship between physical activity and symptoms
during perimenopause.
Hammar, Berg, and Lindgren (1990) investigated the relationship of
frequency of moderate and severe hot flashes to physical exercise. A control
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group of 1 246 women aged 52 and 54 year old in Sweden was compared with
a study group {n

= 142).

They found that moderate and severe psychosomatic

symptoms of hot flashes and sweating were only half as common among the
physically active postmenopausal women (21.5%) as in the control group
(43.8%). The limitation of the study is that the levels of physical activity in the
control group were not measured, therefore, some of the women in the control
group may also have been physically active.

In addition, this study did not

measure the body mass index which may serve as a confounding variable, since
adipose tissue, which converts adrenal androgens to estrogens, may alleviate
menopausal symptoms, and consequently, women with a high body mass index
may be less likely to have menopausal symptoms. Whether or not there was
a true difference in body mass between the two study groups is not known.
The current study controled this confounding variable using a statistical
method.
In summary, the effectiveness of physical activity on perimenopausal
symptoms is promising but needed further empirical evaluation.

Previous

studies had not examined the possible benefits of long-term regular physical
activity on the subsequent risk of occurrence of perimenopausal symptoms.
The majority of physical activity research evaluates the level of current physical
exercise or a short term exercise session. Gannon (1988) indicated that even
if a hormone is found to increase from pre to postexercise, it does not
necessarily indicate that the basal level of such a hormone will respond in the
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same manner to a regular physical activity pattern or exercise program.

In

addition, a history of recent physical activity is closely related to overall general
health (Shinton & Sagar, 1993). Thus the relation between perimenopausal
symptoms and recent exercise can be confounded by illnesses.

A regular

physical activity pattern was examined in this study in order to minimize this
threat to design validity.
Further, research in the past has suggested that the strenuous exercise
required of professional athletes may lead to a reduction of estrogen levels in
normally menstruating women (Gannon, 1988). In order for the results of this
study to be of practical import and realistic for most women, physical activity
of moderate to vigorous intensity was studied. Therefore, the proposed study
evaluate the influence of long term, regular, moderate and vigorous intensity
physical activity on perimenopausal symptoms.
Demographic Influences
Demographic factors

such

as social

class,

years of education,

employment status, marital status and social network have been the focus of
a number of studies with interesting and disparate findings. Wasti, Robinson,
Akhtar, Khan, and Badaruddin (1993), in a study of 650 women with natural
menopause, found that women from a higher socioeconomic status reported
more depressed moods than middle class women and those who lived in slums.
The authors explained that perhaps the middle and lower class individuals
overlooked minor symptoms when faced with major socioeconomic problems.
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In contrast, British studies have found that working class women
generally

report

more

symptoms

than

middle

class

women

during

perimenopause (Bebbington, Hurry, & Tennant, 1981; Hunter, 1992). Holte
and Mikkelsen (1991) reported that women's depressed moods were more
common among those who had lower monthly incomes.
Years of education in middle aged women have been demonstrated to be
inversely correlated with symptoms during perimenopause (McKinlay, McKinlay,

& Brambilla, 1987; Dennerstein et al., 1993). For example, Dennerstein et al.
( 1993), in a study of 2000 women between 45 and 55 years, found, with
increasing years of education, women reported fewer psychological symptoms,
better self-rated health, using fewer non-prescription medications, the absence
of chronic health conditions, a low level of interpersonal stress, the absence of
premenstrual complaints, not currently smoking, and had positive attitudes
toward aging and menopause.
Unemployment has also been shown to contribute to the incidence of
symptoms during menopause (Hunter, 1992). Midlife women who work (i.e.,
have a paying job) are more likely to be fired, laid off or leave voluntarily when
compared to men. Crowley ( 1 991 ) suggests that people who lose their jobs
often experience a type of grief reaction followed by depression. Furthermore,
older workers who are laid off are unattractive to subsequent employers, being
close to the end of their working lives (Crowley, 1991 ). Perhaps lack of job
security and difficulty in employment are also factors noted in the greater
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incidence of depression in menopause.
Similarly, Roy ( 1987) indicated that women who lack any form of full or
part-time employment outside the home are more likely to suffer depression in
the presence of stressful life events or difficulty.

Jennings and colleagues

( 1 984), in their cross-sectional study, found that while unemployed women
were the least healthy, full-time homemakers reported worse emotional health
than employed women.

Perhaps lack of financial independence is also an

important factor in the occurrence of depression in menopause.
In addition, recent studies have found that menopausal women who are
divorced, widowed or separated are more likely to be depressed, followed by
married women, with single women having the fewest problems (Hunter, 1990;
McKinlay, McKinlay, & Brambilla, 1987).

In general, studies of marital,

employment and socio-economic status have produced mixed results, probably
because these variables interact in complex ways.

For example, in the

Massachusetts study (McKinlay et al., 1987), there was an interaction between
years of education and marital status, with the less educated women who were
divorced or separated being most prone to depressed moods. Therefore, the
interactions among psychosocial variables need to be considered. In this study,
data on demographic variables were collected and analyzed as covariates.
Levels of estrogen have been related to the percentage of body fat since
adipose tissue is one source of estrogen.

In order to investigate the

relationship between physical activity and perimenopausal symptoms, the
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percent of body fat should be taken into consideration.

In this study, body

mass index was used to estimate the percentage of body fat.
The Aims of the Study
The aims of the study were:
1.

a.

To describe the frequency of symptoms in perimenopausal
women.

2.

b.

To describe the distress of symptoms in perimenopausal women.

a.

To evaluate the effect of current physical activity on the
frequency of perimenopausal symptoms.

b.

To evaluate the effect of current physical activity on the distress
of perimenopausal symptoms.

3.

a.

To evaluate the effect of long term physical activity on the
frequency of perimenopausal symptoms.

b.

To evaluate the effect of long term physical activity on the
distress of perimenopausal symptoms.
Operational Definitions

1.

Perimenopause:
is defined as experiencing changes in menstrual pattern such as irregular
menstruation or no menstruation for 3 to 11 months.

2.

Physical activity:
is any bodily movement produced by skeletal muscles that results in
energy expenditure.
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3.

Exercise:
is a subset of physical activity defined as planned, structured, and
repetitive bodily movement done to improve or maintain one or more
components of physical fitness

4.

Moderate physical activity:
is an activity performed at an intensity of 3 to 6 METs (work metabolic
rate/resting metabolic rate)-the equivalent of brisk walking at 3 to 4 mph
for most healthy adults.

Examples include briskly walking (3-4 mph);

cycling for pleasure or transportation ( < 10 mph), moderate effort
swimming, general calisthenics, table tennis, golf (pulling cart or carrying
clubs), fishing (standing/casting), leisurely canoeing (2.0-3.9 mph),
painting (home repair), mowing lawn (power mower).
5.

Vigorous physical activity:
is an activity performed at an intensity of 6 or more METs. Examples
include briskly walking uphill or with a load, fast or racing cycling ( > 10
mph), fast treading or crawl swimming, stair ergo meter, ski machine
conditioning exercise, singles tennis, racketball, fishing in stream, rapidly
canoeing ( > 4 mph), moving furniture, mowing lawn (hand mower).

6.

Currently active:
individuals who accumulate 1 50 minutes or more of moderate to
vigorous-intensity physical activity per week during the past month.
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7.

Currently relatively active:
individuals who accumulate 30-149 minutes of moderate to vigorousintensity physical activity perweek during the past month.

8.

Currently inactive:
individuals who do none or less than 30 minutes of moderate and
vigorous physical activity per week during the past month.

9.

Long-term active:
individuals who accumulate 1 50 minites or more of moderate to vigorous
physical activity per week over the past 10 years

10.

Long-term inactive:
individuals who do none or less than 30 minutes of moderate to vigorous
physical activity per week over the past 5 years.

11.

Long-term relatively active:
individuals who were not belonging to either long-term inactive or longterm active group.

CHAPTER Ill
METHODS
Sample
The sample consisted of perimenopausal women who were participants
in Women Take Heart, a community-based study evaluating women's risk of
coronary heart disease. Using the power analysis model, to detect an R2 of at
least 15% with 7 predictor variables (physical activity, age, years of education,
employment status, marital status, social class and BMI) (beta= .20; power
= .80; alpha = .05), a minimum of 88 women were necessary for the study.
Selection Criteria
Subjects included women who were perimenopausal and aged 40 and
above.

Perimenopause was defined as experiencing changes in menstrual

pattern which includes menstrual irregularity or no menstruation for three to 11
months. Using only the perimenopausal women as subjects, it was possible to
separate the effect of physical activity from that of menopausal status on
symptoms associated with perimenopause. Potential subjects were excluded
from the study if they: had a history of hysterectomy and/or bilateral
oophorectomy; were currently pregnant; were currently or previously on
hormone replacement therapy; have been on oral contraceptives within the past
five years.

Professional athletes were also excluded from the study since
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intense training, or overtraining, consistently results in increased mood
disturbance (Raglin, 1990).

In addition, intense training may result in

amenorrhea.
Design
The design was a cross-sectional, correlational, one factor design with
three levels for the factor. The factor was the levels of physical activity. Three
groups of women were studied: inactive, relatively active, and active.

The

dependent variables included perimenopausal symptoms and four subscales of
the Women's Health Assessment Scale (menstrual change, vasomotor
symptoms, psychosomatic symptoms, and sexual health). The independent
variable was the amount of physical activity (level= 3). Covariates included
age, years of education, employment status, marital status, social class and
body mass index.
Measurements
Menopausal Symptoms
The Women's Health Assessment Scale (see Appendix F) was developed
from two sources: The Women's Health Questionnaire (Hunter, 1986) and the
21-item Kaufert and Syrotuik Symptoms Index ( Kaufert et al., 1 988). The
Women's Health Questionnaire consists of nine subscales and 35 items to
assess the following areas: somatic (7 items), depressed mood (7 items),
cognitive difficulties (3 items), anxiety/fears (4 items), sexual functioning (3
items), vasomotor symptoms (2 items), sleep problems (3 items), menstrual
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problems (4 items), and attractiveness (2 items). Frequency of the symptoms
over the past several months was scored on a four-point scale as 0 = "no, not
at all; 1 = "No, not much"; 2= "yes, sometimes"; or 3= "yes, definitely".
The concurrent validity of the questionnaire was reported to be .80 and testretest reliability was .86 (Hunter, 1986). The strengths of the questionnaire
include that it measured 1) depressed mood which is more menopause-related
than clinical depression; and 2) the sexual health of perimenopausal women.
The 21-item Kaufert and Syrotuik Symptoms Index assesses four areas:
vasomotor (2 items), genitourinary (3 items), psychologic (6 items), and general
health symptoms ( 10 items) ( Kaufert & Syrotuik, 1981).

Frequency of the

symptoms over the past several months is scored on a three-point scale as 0 =
"never"; 1 ="sometimes"; or 2= "often". The questionnaire has been used
in a number of previous studies of midlife women (Kaufert, 1988; Wilbur et al.,
1 992). Wilbur et al. ( 1 992) found that the questionnaire was reliable and the
six nervous symptoms were positively related to the Center for Epidemiological
Studies' Depression Scale.
In summary, although The Women's Health Questionnaire (Hunter, 1986)
and the 21-item Kaufert and Syrotuik Symptoms Index are reliable tools to
measure menopausal

symptoms;

however,

they

lack two

important

components which are critical for perimenopausal women. First, they do not
measure to what degree perimenopausal symptoms upset or distressed midlife
women. Second, they do not measure menstrual problems that perimenopausal
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women may experience. Therefore, the Women's Health Assessment Scale
which does address these areas was developed for this study.
When developing the Women's Health Assessment Scale, items from the
Women's Health Questionnaire and the 21-item

Kaufert and Syrotuik

Symptoms Index (Kaufert et al., 1988) were compiled. When items from those
two instruments were similar, one was selected.

In addition, five items

concerning the menstruating problems which frequently occurred during
perimenopause were added to the questionnaire. The final questionnaire, the
Women' Health Assessment Scale, consists of 47 items.

In relation to the

symptom aspect of the new tool, both frequency and degree of distress or
bothersomeness were rated. Frequency of the symptoms over the past several
months was scored on a five-point scale as 0 = "never", 1 = "rarely", 2 =
"sometimes" 3

=

"often", or 4 = "always".

Degree of bothersomeness or

distress of symptoms was also scored on a five-point scale as 0 = "not at all",
1 = "a little", 2 = "moderately", 3 = "quite a bit", or 4 = "extremely". Scores
were averaged for each dimension separately. The sum of scores on all items
for each dimension was used to indicate the total perimenopausal symptom
frequency and distress scores.

The score on items of each subscale were

summed to indicate total subscale scores.

Face and content validity of

Women's Health Assessment Scale were established for the modified tool by
a panel of five experts. Cronbach's alpha was used to determine internal
consistency. The strengths of the Women's Health Assessment scale included
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that

it contains

the

measurements

of

1 ) frequency

and

degree of

bothersomeness or distress of perimenopausal symptoms and 2) occurrence of
menstrual symptoms.

Therefore, it is more applicable to perimenopausal

women.
Physical Activity
A Physical Activity Questionnaire (see Appendix F) was developed based
on the physical activity questionnaire in Sturgeon and colleague's study
(Sturgeon et al., 1993). The Physical Activity Questionnaire consisted of two
dimensions: current and long-term physical activity. Items estimating activity
level on each of two aspects: moderate and vigorous activity were included.
Current activity measured the amount of moderate to vigorous activity during
the past month. Long-term activity measured the regular activity pattern which
included the dose and duration of activity.

Scores were averaged for each

dimension separately to give subscale measures of moderate and vigorous
physical activity. The long-term averages on each dimension were summed to
indicate total regular physical activity.
American Heart Association Physical Activity Questionnaire (AHAPAQ)
measures physical activity pattern on a 5-point scale with 0 =inactive and
4 =highly active. AHAPAQ was used to evaluate the construct validity of the
Physical Activity Questionnaire for this study.
Demographic Variables
Demographic variables including age, years of education, employment
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status, marital status, and BMI were measured using a data collection tool
addressing demographic information and health history (see Appendix F).
Procedure
After receiving Institutional Review Board approval (see Appendix G), a
pilot study was conducted before the actual study began to evaluate the
reliability of the tools. Seventy-two nursing faculty and staff were contacted
in order to obtain the pilot sample of 22. A cover letter (Appendix J) explaining
the purpose of the study and a survey packet, which included questionnaires
and a stamped and addressed envelope for returning the questionnaires, were
mailed to all potential subjects.

In the cover letter, women were asked to

participate in the study and informed that their consent to be subjects would
be indicated by their completion and return of the questionnaire.
Twenty-two completed questionnaires were returned. The age of the
subjects ranged from 41 to 55 years, with a mean age of 48.2 years (sd

= 3.8).

Twenty (91 %) subjects were white, one Black (4.5%) and one Hispanic
(4.5%). The subjects weighed an average of 169 pounds (sd

= 33.3;

range

=

127 to 238 pounds). All subjects were undergoing perimenopause.
Content validity of the questionnaires were evaluated by five content
specialists (three menopause researchers, one exercise expert and one tool
development expert).

A few item-modifications were made before the pilot

study.
The reliability of the tool was determined based on internal consistency.
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Cronbach's alpha for both dimensions of the Women's Health Assessment
Scale met the accepted standard of . 70 indicating the homogeneity reliability
of the scale (the Cronbach alpha was .94 for symptom frequency and .91 for
symptom distress. There were 47 items in each dimension.
Cronbach alpha for the physical activity questionnaire (Cronbach
alpha=. 61

and number of items= 10) did not meet the standard for

homogeneity reliability evaluation which may be explained by the small number
of items on the tool.

Multicollinearity was not found to be a problem as

indicated by few inter-item correlations greater than . 70.
Based on the results of the pilot study, no changes were made to the
WHA questionnaire. Four items describing the type of activity were added to
the physical activity questionnaire.
After the reliabilities of the tools were established, database for the
Women Take Heart program was used to obtain the names, phone numbers,
and addresses of the perimenopausal women. Then, a cover letter (Appendix
H) explaining the purpose of the study and a survey packet, which included
questionnaires and a stamped and addressed envelope for returning the
questionnaires, was mailed to all potential subjects. In the cover letter, women
were asked to participate in the study and informed that their consent to be
subjects would be indicated by their completion and return of the questionnaire.
Three weeks after the initial mailing, if no response was received, follow-up
telephone calls were made. A second mailing was made to potential subjects
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who: 1) were reached by telephone and indicated they were willing to
participate, but either never received the first questionnaire packet or mislaid
it, and 2) were not successfully reached by telephone. Twenty percent of the
perimenopausal women who did complete and return their questionnaires, were
requested to complete the same questionnaire two weeks later for the purpose
of test-retest reliability analysis (see Appendix I). A total of 35 women were
retested.
Data Analysis
Data analysis techniques specific to each research question of the study
are listed below.

Internal consistency for each tool was determined by

Cronbach alpha. The significance level was set at p < 0.05.
AIM 1.

To describe the frequency and associated distress of symptoms in

perimenopausal women.
Descriptive statistics were used to describe demographic information and
the frequency and degree of distress or bothersomeness of perimenopausal
symptoms.
AIM 2. To evaluate the influence of current physical activity on the frequency
and distress of perimenopausal symptoms.
To accomplish this aim, two steps were used. First, perimenopausal
symptoms (total score for each dimension) were used as a single dependent
variable and an ANCOVA with covariates were performed. Second, MANCOVA
with covariates was used to detect differences on four subscales in three
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different groups.
Before the ANCOVA was used, the statistical assumptions were checked
before any test. For ANCOVA procedure, as a first step, a check was made to
determine if significant interactions between each of the covariates and the
independent variable on perimenopausal symptoms (total score for each
dimension).

All covariates, and significant interaction terms were entered in

the analysis. If a significant F-test for any of the covariates was found it would
indicate a significant effect for that particular term on perimenopausal
symptoms.

The terms in each covariance model were trimmed to eliminate

non-significant elements.
When applying the MANCOVA model, significant interactions between
each of the covariates and the independent variable on each dimension of
perimenopausal symptoms were also examined. Assuming equal slopes of a
given covariate on perimenopausal symptoms in each of the cells of the design,
a more complex analysis of covariance was undertaken as appropriate.

All

covariates, and significant interaction terms were entered in the analysis.
Similar to ANCOV A, a significant F-test for any of the covariates would indicate
a significant effect for that particular term on perimenopausal symptoms. The
terms in each covariance model will be trimmed to eliminate non-significant
elements.
AIM 3.

To evaluate the effect of long-term physical activity level on the

frequency and distress of perimenopausal symptoms
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Analysis methods used in AIM 2 were used for this aim.
Potential Risks
To pretect individuals from the threat of loss of confidentiality, code
numbers were assigned to each subject. Only the study code number appeared
on the questionnaires and records.

A master list of names, addresses, and

code numbers was maintained in the event that follow-up was needed. But
this list was available only to the investigator and will be destroyed when the
study was completed. There were no any other known risks involved in this
study except the time and invonvenience required for completion of the
questionnaires.
Limitations of the Study
1.

This study was limited by its cross-sectional design since long-term recall
was involved, the study results might be limited by recall bias.

2.

There were no objective measures used in this study.

It relied on the

self-report of the women subjects. The use of only self-report data to
examine physical activity behaviors and symptoms may present some
threat to internal validity. Each individual's perception may play a role
in her response to the questionnaire.

There was the possibility that

some respondents reported their behaviors more as they think it should
have been rather than as it was.

CHAPTER IV
RESULTS
Profile of the Sample
Of the 840 questionnaires distributed to women aged 40 to 55 years,
424 were returned, with a response rate of 51 %.
participated

in the pilot study were

included,

When women who

35. 7%

(n = 159) were

premenopausal, 5.8% (n=26) postmenopausal, 10.5% (n=47) were taking
hormones or oral contraceptives. This left 214 usable responses. To ensure
complete data, women were contacted by phone to complete unanswered
questions and to verify responses when necessary. Therefore, missing data
were minimal. For Women's Health Assessment Scale, serial means were used
for the missing data points. For the Physical Activity Questionnaire, subjects
with missing data were deleted analysis by analysis.
The report of the results are divided into two sections: psychometric
analysis of instruments and findings relative to research questions.
Psychometric Analysis of Instruments
The total sample (n = 214) was used to establish internal consistency
reliabilities on the instruments. Measurements of internal consistency reliability
were made on all of the instruments in this study.

Cronbach alphas were

computed for each subscale within the instruments. The test-retest method
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was used to determine the stability reliability (repeatability) of the instruments.
Women's Health Assessment Scale (WHAS)
Symptom frequency dimension of WHAS
The items measuring symptom frequency on the WHAS scale were
analyzed for internal consistency reliability.

The Cronbach alpha for the

symptom frequency (47 items) for the entire sample was .91. The internal
consistency reliabilities for the subscales for the entire samples are presented
in Table 2. It should be noted that an extremely high alpha coefficient is not
necessarily desirable since this would indicate that items are too similar and
thus, redundant (Cattell, 1978).
To assess the possibility of redundancy, the inter-item correlations were
analyzed.

There were only a few correlations greater than . 70 indicating

redundancy is less likely a problem. The high crobach alphas for total scale and
psychosomatic scale may be explained by the greater number of item in those
scales.
The homogeneity reliability was also analyzed by correlating subscale
scores with the total scale score (Hinshow and Atwood, 1982). All the
subscales were significantly correlated with the total scale (all P values

< .00;

r = .31 to .97) indicating the contributions of the subscales to the total scale
(see Table 3).

The psychosomatic subscale contributed the most while the

vasomotor symptoms did the least to the the total scale.
The subscale scores were further correlated with each other to
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investigate

possible overlap between

the

subscales.

The correlation

coefficients ranged from low to moderate (r = .07 to .38) (see Table 4). The
highest correlation coefficients were between psychosomatic symptoms and
sexual health.

Table 2.
Homogeneity reliability: WHAS
(n = 214)
Cronbach's alpha

No of items

total score

0.91

47

vasomotor symptoms

0.49

2

psychosomatic symptoms

0.92

36

menstrual problems

0.19

5

sexual health

0.75

4

total score

0.92

47

vasomotor symptoms

0.55

2

psychosomatic symptoms

0.92

36

menstrual problems

0.58

5

sexual health

0.76

4

Scale/subscale
Symptom Frequency

Symptom Distress
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Table 3.
Correlations between subscale scores and total scale score of symptom
frequencies of WHAS (n = 214)
scale

correlation
coefficient (r)

P value

Total score and vasomotor symptoms score

0.30

.000

Total score and psychosomatic score

0.97

.000

Total score and menstrual problems

0.45

.000

Total score and sexual health

0.55

.000

Table 4.
Correlation matrix of symptom frequency dimension of WHAS
Subscale

Vasomotor
symptoms (r)

Psychosomatic
symptoms (r)

Vasomotor
symptoms

1

Psychosomatic
symptoms

0.22; 0.00

1

Menstrual
problems

0.07; 0.16

0.35; 0.00

1

Sexual health

0.19; 0.00

0.40; 0.00

0.26; 0.00

Menstrual
problems
(r)

Sexual
health
(r)

1
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Stability reliability was used to examine the extent to which WHAS yields
similar results with the sample over time. The test-retest method was used to
determine the stability reliability (repeatability) of the instrument. Thirty-five
women were retested after two weeks. Spearman's correlation coefficients of
the test-retest data indicated that the instrument was reliable (total score:
r = 0.85, p = .000; vasomotor symptoms: r = 0.86 p = .000; psychosomatic
symptoms: r = 0.83, p = .000; menstrual problem: r = 0. 76, p = .000; and sexual
health: r = 0.91, p = .000) (see Table 5).
significant at .05.

All correlations obtained were

Sexual health was the most stable subscale.

Stability

reliability of the instrument was therefore supported by these results.
Symptom distress dimension of WHAS
The same methods were used to analyze the internal consistency and
repeatability of the symptom distress dimension of the scale. The Cronbach
alpha for the symptom distress dimension (47 items) was .92. which meets the
acceptable standard of. 70 cited by Nunnally ( 1978), therefore, demonstrating
support for homogeneity reliability of this dimension. The correlation
coefficients of subscale scores and total scale scores ranged from moderate to
high (.38 to .98) which further supports the homogeneity reliability of this
dimension (see Table 6).
The symptom distress dimension of WHAS exhibited no overlapping
between subscales, as the correlations between subscales ranged from low to
moderate (r = .10- .42) (see Table 7). The highest correlation coefficients were
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between menstrual symptoms and psychosomatic symptoms.

Table 5.
Stability reliability of WHAS
(n = 35)
Scale/subscale

Correlation (r)

Symptom frequency
Total score

0.85*

vasomotor symptoms

0.86*

psychosomatic symptoms

0.83*

menstrual problems

0.76*

sexual health

0.91 *

Symptom distress
total score

0.80*

vasomotor symptoms

0.83*

psychosomatic symptoms

0.81 *

menstrual problems

0.88*

sexual health

0.91 *

* p<0.001
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Table 6.
Correlations between subscale scores and total scale score of symptom
distress of WHAS (n = 214)
Scale

correlation
coefficient (r)

P value

Total score and vasomotor symptoms score

0.38

.000

Total score and psychosomatic score

0.98

.000

Total score and menstrual problems

0.53

.000

Total score and sexual health

0.53

.000

Table 7.
Correlation matrix of symptom distress dimension of WHAS
Psychosomatic
symptoms
(r; p)

Menstrual
problems
(r; p)

Subscale

Vasomotor
symptoms
(r; p)

Vasomotor
symptoms

1

Psychosomatic
symptoms

0.32; 0.00

1

Menstrual
problems

0.1 O; 0.67

0.42; 0.00

1

Sexual health

0.20; 0.00

0.42; 0.00

0.23; 0.00

Sexual
health
(r; p)

1
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The stability reliability of the scale was supported by high correlations
between test and retest data.

All correlations were significant at .05 level

(total score: r = 0.80, p = 0.000; vasomotor symptoms: r = 0.83, p = 0.000;
psychosomatic symptoms: r = ,0.81 p = 0.000; sexual problems: r = 0.88,
p=0.000, and sexual health: r=0.91, p=0.000) (see Table 5).

Again, the

sexual health was the most stable subscale.
Physical Activity Questionnaire (PAQ)
The items measuring physical activity, both current and long-term, were
included in the analysis of internal consistency reliability (only items with same
levels of measurement were included; n = 4). The Cronbach alpha was 0. 79.
The correlations between total score of physical activity questionnaire
and current and long-term score were high (.95 and .95, respectively) further
supporting the homogeneity reliability of the scale. The current and long-term
physical activity were also highly correlated (r = 0.81 ;p = .00) indicating that the
current physical activity may be reflecting a long-term physical activity pattern.
It was possible that women who were currently active have also been longterm active.
The stability reliability of the physical activity scales are presented in
Table 8. All correlations obtained were significant at .05. Stability reliability
of the instrument was therefore supported by these results. It is interesting to
note that long-term activity was more stable than current activity and also more
stable than American Heart Association Physical Activity Questionnaire. For
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both current and long-term activity, vigorous activity was more stable than
moderate activity.

Table 8.
Stability reliability of Physical Activity Questionnaire
(n = 35)
Scale/subscale

Correlation (r)

Current physical activity
Total score

0.79*

vigorous PA

0.81 *

moderate PA

0.60*

Long-term physical activity
total score

0.92*

vigorous PA

0.85*

moderate PA

0.73*

American Health PAO

0.82*

* p<0.001
Validity of the Physical Activity Questionnaire was evaluated by its
correlation with the AHAPAQ.

The correlations for total scale and each

dimension were all significant at 0.001 level (see Table 9) indicating the
construct validity of the scale.
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Table 9.
The correlation between the Physical Activity Questionnaire and the
American Heart Association Physical Activity Questionnaire

Questionnaires

Correlation coefficient

AHAPAQ and current physical activity
total score

0.66*

vigorous PA

0.61 *

moderate PA

0.46*

AHAPAQ and long-term Physical activity

* All Ps

total score

0.56*

vigorous PA

0.55*

moderate PA

0.40*

< 0.05
Study Aims

Data were analyzed to describe the frequency and distress resulting from
symptoms in perimenopausal women.

The data were further analyzed to

evaluate the effect of physical activity on perimenopausal symptoms.

The

statistical significance level for all analyses was set at .05.
The results are presented in the following order: sample characteristics,
the frequency and distress of perimenopausal symptoms, the effect of current
physical activity on perimenopause, the effect of long-term physical activity on
perimenopause and the relationships of quality of life to perimenopausal
symptoms.
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Sample Characteristics
The sample consisted of a total of 214 women, 40-55 years of age, all
of whom were undergoing perimenopause. White women were predominant
in the study, compared to other ethinic groups (89. 7%, n = 192; 10.3%, n = 22
respectively). The mean age of the sample was 47 yrs (sd

= 3.0).

One hundred

and fifty six women (72.9%) were married, four separated (1.9%), six
widowed (2.8%), and twenty-one (9.8%) never married and twenty-six
( 12.1 %) divorced. The majority of women received (97%; n = 206) high school
or higher education. About 88% of the women (n
(n

= 26)

were not working

= 188) were employed;

at the time of the study.

12%

Demographic

characteristics based on current levels of physical activity are detailed in Table
10.
Aim 1 . Frequency and Distress of Perimenopausal Symptoms
Prevalence
Hot flashes which are generally considered as one of the most common
perimenopausal symptoms occurred in 45.8% of the women with 37.3%
reporting the hot flashes as distressful. However, only 13% of the subjects
reported experiencing hot flashes often or always and only 14% reported that
hot flushes were quite a bit or extremely distressful. Hot flashes were not the
most frequent or distressful symptom reported. The most frequently occurring
symptoms were reported to be irregular menstrual flow (86.4%), lack of energy
(74.6%), forgetfulness (67%), irritability (64.8%), stiff joints (62.1 %),
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Table 10.
Demographic characteristics of the sample
(N=214)
Group
Variable

Inactive
(n=59)

Relatively
active (n = 69)

Active
(n = 68)

Age (yrs)
mean (sd)

47.17 (3.3)

47 (2.6)

46. 72 (3.3)

Height (inch)
mean (sd)

64.46 (2.2)

64.8 (2.6)

64. 79 (2. 5)

Weight (kg)
mean (sd)

183.95 (49.6)

159.42 (36.1)

156.06 (36.8)

Race(%)
White
Non-white

82.8
17.2

91.3
8.6

94.1
5.8

Education (yrs)
< 13
13-16
> 16

32.8
46.6
20.7

18.8
49.2
31.9

23.5
51.4
25.0

Marital status (%)
Never married
Married
Separated
Divorced
Widowed

8.6
77.6
3.4
6.9
3.4

11.6
71.0
0.0
14.5
2.9

11.8
70.6
0.0
16.2
1.5

Job Status (%)
Working
Not working

93.2
06.8

89.9
10.1

82.4
17.6

Income
< $20,000
$20,000-100,000
> 100,000

86.2
13.7
0

1.5
84.9
13.6

4.7
83.6
12.5
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difficulty concentrating (58%), bloated stomach (57%), decreased sexual desire
(57%), breast tenderness (56%), and excessive bleeding (54%).

The

symptoms reported to be most distressful were irritability (54.8%), lack of
energy (61.4%), forgetfulness (60%), pain and stiffness of joints (51 %),
headache (53%), difficulty concentrating (53%), bloated stomach (51 %),
irregular menstrual flow (69.4%) and excessive bleeding (50%).
Overall scores and subscale scores
WHAS measures the

frequency

and distress of perimenopausal

symptoms. The symptom frequency scores were computed by dividing the
frequency scores for the total scale and for each subscale by number of items.
The possible range of scores for this method of computation was 0-4. The
mean overall frequency score for all symptoms for the sample was 1 . 11
(sd=0.47; range=0.11-2.49) indicating that the perimenopausal women
experienced symptoms rarely to sometimes. Mean frequency scores for the
four subscales were as follows: Vasomotor symptoms, 0.89 (sd = 0. 78;
range= 0-4); psychosomatic symptoms, 1. 13 (sd = 0. 55; range= 0.03-2. 78);
menstrual problems, 1.26 (sd =0.56; range =0-2.8), and sexual health, 0.97
(sd=0.84; range=0-3.5).

Thus, overall, the perimenopausal symptoms

occurred rarely to sometimes and the menstrual symptoms occurred more
frequently than other types of symptoms.
The five most frequently reported symptoms on a 0-4 scale were: 1)
irregular menstrual flow (mean= 2.08 on a 0-4 scale, sd = 1.21), 2) lack of
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energy (mean= 1.98; sd = 1.12), 3) irritability (mean= 1.82; sd = 1.00), 4) stiff
of joints (mean= 1. 79; sd = 1.25) and 5) forgetfulness (mean= 1. 77; sd = 1.04).
The five least reported symptoms were 1) anxiety leaving the house alone
(mean=0.23; sd=0.59), 2) loss of appetite (mean=0.30; sd=0.64), 3)
bladder infection (mean= 0.32; sd = 0.68), 4) persistent cough (mean= 0.41;
sd = 0.85) and 5) bleeding from the uterus at any time other than during the
menstrual period (mean =0.43; sd =0.74).
Using the same method, symptom distress was computed by dividing the
distress scores for the total scale and for each subscale by number of items.
Again, the possible range of scores was 0-4. The mean overall distress score
for the sample was 1.07 (sd = 0. 57; range= 0-4) indicating, on average,
menopausal symptoms were a little stressful. Mean distress scores for the four
subscales were as follows: Vasomotor symptoms, 0.84 (sd = 0.87; range= 04); psychosomatic symptoms, 1.12 (sd=0.63; range=0.03-3.03); menstrual
problems, 0.95 (sd =0. 71; range =0-3.2), and sexual health, 0.92 (sd =0.93;
range= 0-4). Thus, all perimenopausal symptoms were a little distressful and
psychosomatic symptoms were more stressful than the other types of
symptoms.
The five most distressful symptoms were: 1) lack of energy (mean= 1.94
on

a 0-4 scale,

sd = 1.33),

2)

irritability

(mean= 1.82;

sd = 1.24), 3)

forgetfulness (mean= 1.81; sd = 1.30), 4) headache (mean= 1.66; sd = 1.33)
and 5) excessive bleeding (mean= 1.64; sd = 1.50). The five least reported
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symptoms were 1) loss of appetite (mean= 0. 16; sd = 0.46), 2) anxiety leaving
the house alone (mean =0.22; sd =0.66), 3) persistent cough (mean =0 ..36;
sd = 0.88), 4) deficient amount of menstrual flow with regular periods
(mean= 0.42; sd = 0.86), and 5) bladder infection (mean= 0.45; sd = 1.01 ).
Overview of the Effect of Physical Activity on Perimenopausal Symptoms
Descriptive data for physical activity are shown in table 11 . About one
third of women (34. 7%, n = 68) were currently active and one third were
physically inactive (30.1 %, n = 59).

A quarter of women were performing

vigorous physical activity at least 60 minutes a week. However, only 13.6%
(n = 29) had been active for 10 years or more and about 48.1 % had been
inactive for many years.

Table 11.
Descriptive data of physical activity
Groups

N

%

Currently inactive
Currently relatively active
Currently active

59
69
68

30.1
35.2
34.7

Long-term inactive
Long-term relatively active
Long-term active

103
59
29

48.1
27.6
13.6

Prior to examining the effect of physical activity on perimenopausal
symptoms, the similarities and differences among three groups based on the
current physical activity for demographical variables were evaluated.

Using
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nonparamatric tests for three independent samples, no significant differences
were found between the groups for race, working status, marital status, .and
income. Using one-way analysis of variance, no significant differences were
found between groups for age. However, there was a significant difference
between groups for body mass index (f = 10.05; p = 0.0001 ). Using Turkey's
Honestly Significant Difference (HSD) test to further analyze the locations of
the differences, it was found that the inactive group had a significantly higher
body mass index than the relatively active and the active group. There was no
significant difference in body mass index (BMI) between the relatively active
and active group. Therefore, BMI was used as a covariant in the analyses.
The influence of physical activity on frequencies of perimenopausal
symptoms were examined using ANCOV A for total score and MANCOV A for
subscales. Tukey's HSD tests were used for group comparisons. BMI was not
a significant covariate for any of the analyses.
Aim 2. Effect of Current Physical Activity on Perimenopausal Symptoms
Women were grouped into inactive, relatively active, and active based
on their levels of current physical activity. Group membership was determined
according to the following: inactive

< 30

minute of total current activity in a

week; relatively active: 30-149 minutes of total current activity in a week; and
active:

= or >

150 minutes of total current physical activity in a week. The

descriptive data are shown in Table 12. The inactive group consistently had
the highest means among the three groups on both the frequency and distress
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dimensions and all subscales of perimenopausal symptom subscales.
The tests of significance are shown in Table 13. There were significant
differences among groups in frequency and distress of overall perimenopausal
symptoms (f = 8.86, p = 0.00; f = 6.25; p = 0.00 respectively). The relatively
active and the active groups had significantly less overall frequency of
symptoms and distress related to symptoms than the inactive group. However,
the effect of physical activity seems not to be dose-dependent. The active
group experienced more symptoms and distress than relatively active group.
The significant multivariate differences were found only in symptom
frequency (F = 2.33; p = 0.02) not in symptom distress subscale (see Table
14). However, univariate tests demonstrated that the differences existed in
psychosomatic symptoms and sexual health for both the frequency (f = 8.05,
p=0.00; f=3.42, p=0.03 respectively) and distress (f=5.80, p=0.00;
f = 3. 74, p = 0.03 respectively) aspects of perimenopausal symptoms (see Table
15).

The inactive group experienced more psychosomatic and sexual

symptoms and also rated psychosomatic and sexual symptoms as more
distressful than the relatively active and active groups. Again the relatively
active group experienced fewer symptoms and less distress than active group.
No significant differences were found among groups in frequency and distress
of vasomotor symptoms and menstrual problems.
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Table 12.
Descriptive data for perimenopausal symptoms based on levels of
current physical activity

Group

Sample
size

Mean

SD

total score

inactive
relatively active
active

59
69
68

1.29
0.95
1.16

0.45
0.44
0.51

vasomotor

inactive
relatively active
active

59
69
68

1.01
0.76
0.93

0.80
0.73
0.80

psychosomatic

inactive
relatively active
active

59
69
68

1.32
0.94
1.17

0.50
0.49
0.58

menstrual problem

inactive
relatively active
active

59
69
68

1.36
1.17
1.26

0.55
0.58
0.52

sexual health

inactive
relatively active
active

59
69
68

1.16
0.77
1.08

0.81
0.73
0.96

total score

inactive
relatively active
active

59
69
68

1.24
0.89
1.09

0.54
0.50
0.61

vasomotor

inactive
relatively active
active

59
69
68

0.94
0.76
0.84

0.85
0.85
0.91

psychosomatic

inactive
relatively active
active

59
69
68

1.30
0.93
1.13

0.61
0.57
0.65

menstrual problem

inactive
relatively active
active

59
69
68

1.07
0.87
0.98

0.72
0.65
0.69

sexual health

inactive
relatively active
active

59
69
68

1.09
0.69
1.07

0.98
0.76
1.07

Scale/subscale
Symptom frequency

Symptom distress

Table 13.
ANOV A for perimenopausal symptoms based on levels of current physical activity
Symptom frequency
/distress

Source of
Variance

DF

SS

MS

F-ratio

p

Symptom frequency

between groups
within groups
total

2
193
195

3.86
42.07
45.93

1.93
0.22

8.86

0.00*

Symptom distress

between groups
within groups
total

2
193
195

3.82
58.95
62.77

1.91
0.31

6.25

0.00*

Table 14.
Multivariate tests of significance for subscales of perimenopausal symptoms based on
current physical activity
Symptom frequency
/distress

DF

Wilks Lambda

F

p

Symptom frequency (with four
subscales)

8, 380

0.91

2.33

0.02*

Symptom distress (with four
subscale)

8, 380

0.93

1.79

0.07

........
0

Table 15.
Univariate tests for subscales of perimenopausal symptoms based on levels of current physical activity
Symptom frequency /distress

OF

SS

MS

F-ratio

p

Symptom frequency
vasomotor
psychosomatic
menstrual
sexual health

(2, 193)
(2, 193)
(2, 193)
(2, 193)

2.07
4.45
1.10
4.87

1.03
2.22
0.55
2.43

1.72
8.05
1.82
3.42

0.18
0.00*
0.17
0.03*

Symptom distress
vasomotor
psychosomatic
menstrual
sexual health

(2, 193)
(2, 193)
(2, 193)
(2, 193)

1.04
4.32
1.21
6.61

0.52
2.16
0.61
3.31

0.69
5.80
1.29
3.74

0.51
0.00*
0.28
0.03*

'-!
,_.
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AIM 3. Effect of Long-term Physical Activity on Perimenopausal Symptoms
Women were divided into three groups based on the levels of long-term
physical activity. Rules for group membership included: inactive:
of physical activity a week for the past five years; active:

< 30 minutes

> 150 minutes of

activity a week for the past 10 or more years; and relatively active: women not
belonging to either group.

Descriptive data are shown in Table 16.

The

inactive group consistently had the highest means among the three groups on
both the frequency and distress dimensions and all subscales of perimenopausal
symptoms.

The ANOV A tests for differences among groups on overall

symptom frequency and distress are shown in Table 17.

No significant

differences were found. The multivariate tests of significance are shown in
Table 18. There was a significant difference among the means of subscales of
symptom occurrence (f = 1.98; p = 0.04), but not that of symptom distress.
Univariate tests demonstrated that the differences existed in psychosomatic
symptoms (f=3.24, p=0.04) (see Table 19). The inactive group experienced
more psychosomatic symptoms than the relatively active and active groups.
Again, the effect of physical activity seems not to be dose-dependent. The
relatively active group experienced fewer psychosomatic symptoms than the
active group.

There were no significant differences among groups in

vasomotor, menstrual, and sexual problems.
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Table 16.
Descriptive data for perimenopausal symptoms based on levels of long-term
physical activity

Group

Sample
size

Mean

SD

total score

inactive
relatively active
active

103
59
29

1.21
1.03
1.13

0.49
0.50
0.48

vasomotor

inactive
relatively active
active

103
59
29

0.88
0.88
1.17

0.78
0.82
0.74

psychosomatic

inactive
relatively active
active

103
59
29

1.24
1.01
1.13

0.55
0.55
0.56

menstrual problem

inactive
relatively active
active

103
59
29

1.28
1.19
1.37

0.58
0.56
0.53

sexual health

inactive
relatively active
active

103
59
29

0.95
1.02
0.90

0.77
0.92
0.90

total score

inactive
relatively active
active

103
59
29

1.15
1.00
1.07

0.59
0.58
0.57

vasomotor

inactive
relatively active
active

103
59
29

0.83
0.85
1.05

0.86
0.90
0.91

psychosomatic

inactive
relatively active
active

103
59
29

1.22
1.01
1.10

0.65
0.60
0.63

menstrual problem

inactive
relatively active
active

103
59
29

0.95
0.95
1.05

0.71
0.68
0.73

sexual health

inactive
relatively active
active

103
59
29

0.90
1.02
0.84

0.92
1.02
0.92

Scale/subscale
Symptom frequency

Symptom distress

Table 17.
ANOVA for perimenopausal symptoms based on levels of long-term physical activity

Symptom frequency
/distress

Source of
Variance

DF

SS

MS

F-ratio

p

Symptom frequency

between groups
within groups
total

2
188
188

1.17
45.22
46.39

0.58
0.24

2.42

0.09

Symptom distress

between groups
within groups
total

2
188
188

0.88
62.22
63.10

0.44
0.33

1.33

0.27

Table 18.
Multivariate tests of significance for subscales of perimenopausal symptoms based on levels of
long-term physical activity

Symptom frequency
/distress

DF

Wilks Lambda

F

p

Symptom frequency (with four
subscales)

8

0.92

1.98

0.04*

Symptom distress (with four
subscale)

8

0.96

0.95

0.46

-..J
~

Table 19.
Univariate tests of significance for subscales of perimenopausal symptoms based on levels of
long-term physical activity

Symptom frequency /distress

OF

SS

MS

F-ratio

p

Symptom frequency
vasomotor
psychosomatic
menstrual
sexual health

(2, 182)
(2, 182)
(2, 182)
(2, 182)

2.02
1.95
0.72
0.39

1.01
0.98
0.36
0.19

1.63
3.24
1.13
0.27

0.20
0.04*
0.33
0.76

Symptom distress
vasomotor
psychosomatic
menstrual
sexual health

(2, 182)
(2, 182)
(2, 182)
(2, 182)

1.00
0.75
0.31
0.81

0.50
0.37
0.15
0.40

0.63
0.96
0.30
0.45

0.53
0.39
0.74
0.64

.......
\JI

76
Additional Findings
The relationships between perimenopausal symptoms and quality

o~

life

variables were also analyzed.
The relationship between perimenopausal symptoms and overall quality
of life
All aspects of perimenopausal symptoms except frequency of vasomotor
symptoms were significantly correlated with quality of life (see table 20).
Multiple regression was used to identify aspects of symptoms which were
predictable of women's quality of life during perimenopause. It was found that
the frequency of psychosomatic symptoms was the single significant symptom
subscale predicting quality of life.

The fewer psychosomatic symptoms a

woman experienced, the better her quality of life during perimenopause. The
frequency of psychosomatic symptoms as a single factor accounted for 32%
of variance (see Table 21 ).
Comparison in quality of life before and during perimenopause
The quality of life during perimenopause was compared with the quality
of life before perimenopause, using Wilcoxon matched pairs singed-ranks test.
Women had significantly decreased quality of life during perimenopause (z = -

6.97; p = 0.00).

'II
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Table 20.
The correlations between perimenopausal symptoms and
overall quality of life

Scale/subscale

Quality of Life {r; p)

Symptom frequency
total score

-0.55; 0.00*

vasomotor symptoms

-0.07; 0.15

psychosomatic symptoms

-0.55; 0.00*

menstrual problems

-0.20; 0.00*

sexual health

-0.30; 0.00*

Symptom distress
total score

-0.54; 0.00*

vasomotor symptoms

-0.14; 0.02 *

psychosomatic symptoms

-0.54; 0.00*

menstrual problems

-0.21; 0.00*

sexual health

-0.31; 0.00*

* P<.05
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Table 21.
Multiple regression of quality of life on perimenopausal symptoms
BETA

T

p

vasomotor symptoms

0.06

0.53

0.60

psychosomatic symptoms

-0.55

-9.63

0.00*

menstrual problems

-0.02

-0.19

0.85

sexual health

0.01

0.06

0.95

vasomotor symptoms

-0.00

-0.02

0.99

psychosomatic symptoms

-0.13

-0.76

0.45

menstrual problems

0.04

0.52

0.60

sexual health

-0.11

0.71

0.48

Perimenopausal symptoms
Symptom frequency

Symptom distress

* P<.05
R2=32%
Model: f=12.06; p=0.00
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Summary of Findings
The following summarizes the important findings of the influence of
physical activity on perimenopausal symptoms in 214 perimenopausal women:
1.

The Women's Health Assessment Scale and the Physical Activity
Questionnaires were reliable instruments for measuring perimenopausal
symptoms and physical activity respectively.

2.

Mean age of perimenopause was 4 7 years.

3.

More than two-thirds of perimenopausal women experienced hot flashes.
However, only 13.5% experienced the symptom often or all the time and
only about 14% reported that the symptom was quite a bit or extremely
distressful.

4.

The most frequent and distressful symptoms were psychosomatic such
as irritability, lack of energy, forgetfulness, stiff joints, and menstrual
problems such as irregular menstruation and excessive bleeding.

5.

About one third of women were currently active, one third relatively
active and one third inactive. Only about 15.2% of the women had been
active for 10 years or more, and more than one half of the women were
inactive for over 10 years.

6.

Total amount of weekly physical activity had significant effects on both
dimensions of perimenopausal symptoms. Relatively active and active
women had significantly fewer total symptoms, psychosomatic and
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sexual symptoms than the inactive group. They also experienced less
distress for psychosomatic and sexual symptoms than the inactive
group. However, the effect of physical activity was not dose dependent
because the relatively active group experienced fewer symptoms and
less distress and the active group.
7.

Long-term physical activity had significant effects on psychosomatic
symptoms. The relatively active and active group had significantly fewer
psychosomatic symptoms than the inactive group. Again, the effect of
physical activity was not dose dependent. The relatively active group
experienced few psychosomatic symptoms than active group.

8.

Frequency of psychosomatic symptoms was the single significant
subscale predicting quality of life during perimenopause.

This single

factor accounted for 32% of the variance.
9.

Quality of life was lower during perimenopausal versus premenopausal
period.

CHAPTER V
DISCUSSION
The primary aim in this chapter is to discuss the findings in two major
areas: measurement statistics and the findings related to the study aims.
Recommendations for future research and implications for nursing care are also
discussed.
Measurement Statistics of the WHAS and PAO
WHAS
Homogeneity reliability is a measurement of the degree to which items
on the tool are measuring the same attribute.

Cronbach's alpha for both

dimensions of Women's Health Assessment Scale (WHAS) met the accepted
standard of greater than 0. 70, supporting the homogeneity reliability of the
scale. Two subscales, psychosomatic and sexual health, for both dimensions,
also met the standard.
The low Cronbach's alpha for vasomotor symptoms may be explained by
the small number of items (items= 2) since the size of the alpha coefficient is
based on both the average correlation among items and the number of the
items in the tool.

However, the vasomotor subscale did meet the

recommendation given by Helmstadter (1964) that alpha coefficient of 0.50
was sufficient for group comparison.

81

82
It was not surprising that menstrual subscale did not meet the
homogeneity reliability standard because some items composing the subscale
were mutually exclusive.

For example, if a

woman experienced scant

menstruation, she would not experience excessive bleeding.
The subscales of WHAS were significantly correlated with the total scale
for

both

dimensions,

frequency

and

homogeneity reliability of the scale.

distress,

further

supporting

the

The low inter-subscale correlations

indicated that the subscales measured differing dimensions and were not
redundant.
Stability reliability examines the extent to which the instrument yields
similar results with same sample over time.

The WHAS proved stable as

shown by the high correlations between test and retest scores for both
dimensions and all subscales of the tool.

Homogeneity reliability of the Physical Activity Questionnaire was
supported by adequate alpha coefficients and substantial correlations between
the subscales, the current and long-term activity, and total scale. However, the
inter-subscale correlation was also high which may indicate redundancy
between subscales or that current physical activity is a reflection of long-term
physical activity patterns.
Stability reliability of the physical activity questionnaire was well
supported by the strong correlations between test and retest scores.

The
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significant correlation between the Physical Activity Questionnaire and the
American Heart Association questionnaire established the construct validity of
the physical activity questionnaire.
In summary, homogeneity reliability coefficients and stability coefficients
of the WHAS and physical activity questionnaire achieved satisfactory
standards for reliability.

Content validity of the WHAS was adequately

documented and the construct validity of physical activity was established by
these data. WHAS fills a void in the instrumentation available for assessing
perimenopausal symptoms. Future research should focus on replication of the
psychometric procedures using a larger sample size.
Study Aims
This study was designed to examine the influence of physical activity on
perimenopausal symptoms. The main results are compared with the findings
of other recent studies.
Before attempting to interpret the results of frequency and distress of
perimenopausal symptoms, several important related points should be noted.
First, the data consisted of self-reported symptoms which were specified in the
questionnaire but which may have been subject to varying interpretation by the
respondents. Second, although an opportunity was provided for respondents
to list further symptoms, this opportunity was seldom taken. Thus, reporting
was effectively restricted to those symptoms specified in the questionnaire.
This method of data gathering might lead to over-reporting of the specified set
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of symptoms and under-reporting of others, thus creating bias in the results.
Third, in this study, the frequency and distress of each symptom category was
the average rating of each symptom's frequency and distress on a 5 point
scale, ie, from never to always, thus the averages of symptoms in this study
may be artificially high.
Aim 1 . Frequency and Distress of Perimenopausal Symptoms
The overall level of symptoms in this group of women as detected by the
WHAS is comparable with that already noted in studies of women of this age
group in the general population. In this study of apparently healthy women, the
mean overall frequency and the mean overall distress score of perimenopausal
symptoms were 1.11 and 1.07 (ranges, 0 to 4), respectively, suggesting that
symptoms occurred rarely to sometimes and were a little stressful. This finding
is in agreement with other community-based studies in North America showing
that perimenopause was not a major subjective health problem in midlife
women (Avis, McKinlay, 1991; Kaufert, Gilbert, and Hassard, 1988; Mattews
et al., 1990; McKinlay et al., 1991).
Perimenopausal women do experience symptoms and these symptoms
do seem distressful in a small percentage of women.

In this study, it was

found that the most prevalent symptom was menstrual irregularity. This result
was expected because menstrual irregularity is a symbol of entering into the
perimenopausal

stage

of

menopause.

Besides

menstrual

problems,

psychosomatic symptoms occurred more frequently than sexual and vasomotor
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symptoms.

Vasomotor symptoms were the least frequently experienced

symptoms among the four groups of symptoms.

The most distressful

symptoms were psychosomatic symptoms and the least distressful symptoms
were vasomotor symptoms. This finding does not support contemporary health
care view which stresses that women often seek help for vasomotor symptoms
such as hot flashes. It is possible that some women with vasomotor symptoms
may have been excluded from this study due to treatment with hormone
replacement therapy.
No previous studies have reported the occurrence and distress of
perimenopausal symptoms using a 5-point scale. So it is impossible to compare
the means of frequency and distress of perimenopausal symptoms in this study
to that of others.

It is possible, however, to compare the frequency and

distress of perimenopausal symptoms in physically active to inactive women
within the present sample. Physically active women experienced fewer overall
symptoms and less distress.

When each symptom subscale (vasomotor,

psychosomatic, menstrual and sexual health) was broken down into its
component symptoms, comparisons were made with the findings of other
studies.
Vasomotor symptoms
The prevalence of the occurrence of hot flashes was 45.8%, which is
comparable with majority of the previous studies in western countries (Mckinlay
et al., 1992; Jaszman et al., 1969; Hunter, 1992; Koster & Davidsen, 1993)
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(see Table 3). However, this prevalence is still higher than that reported for
Australian (Dennerstein et al., 1993) and Canadian women (Kaufert et al.,
1992) (see Table 3).
The distress associated with vasomotor symptoms has been often
ignored by other investigators. In this study, it was found that only 14% of
perimenopausal women reported that hot flashes were quite a bit or extremely
distressful. For most women hot flashes were in fact relatively easy to cope
with, probably because they are characteristically short-lived (duration
approximately 3 minutes) and occurred infrequently in most women.

Many

women were bothered more by the psychosomatic complaints for which they
often did not have an explanation, and for which they sought medical care.
This finding is in agreement with findings reported by Oldenhave et al. ( 1 993)
and Boulet et al. ( 1 994). In their studies, it was found that women suffering
from psychosomatic complaints were more likely to have consulted their
physicians than women suffering from hot flashes and night sweating.
Menstrual problems
The prevalence of menstrual irregularity (86.4%), the most common
symptom in perimenopausal women, was consistent with previous studies by
McKinlay, Brambilla, and Posner ( 1992), Seltzer et al. ( 1990), and Treloar et al.
(1967). They found that approximately 90% of women experienced menstrual
irregularity

during

perimenopausal

years,

and

that

premenopausal women will have sudden amenorrhea.

only

10-12%

of
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Menstrual problems were the second most distressful perimenopausal
symptom. This finding is consistent with the view of McKinlay et al. ( 1992)
who indicated that abnormal bleeding can be disturbing, especially if it is heavy
and unpredictable. These investigators further indicated that irregular menstrual
bleeding during perimenopause appears to be more worrisome to women than
hot flashes, particularly if this irregular menstrual bleeding persists beyond a
year or two.
Psychosomatic symptoms
The

most

frequently

experienced

psychosomatic

symptoms

in

perimenopausal women in this study included irritability (64.8%), forgetfulness
(67%), lack of energy (74.6%), stiff joints (62.1 %), and headache (54.2%). In
comparison with those reporting vasomotor complaints, the percentage of
women experiencing psychosomatic complaints were relatively high. This
finding is in agreement with previous studies (Dennerstein et al., 1993; Greene,
1976; Kaufert, Syrotuik, 1981; Mikkelsen, Holte, 1982; Oldenhave et al.,
1993; Holte, 1992; and Boulet, et al., 1994) (see Table 3). The high
percentages of women reporting psychosomatic symptoms might be an
indicator of general distress experienced around the perimenopausal years, such
as the realization that one is aging.

When these symptoms are viewed as
'

individual symptoms, irritability, lack of energy and headache are consistently
among the top five symptoms reported across studies (Dennerstein et al.,
1993; Jaszmann, Van Lith, and Zaat, 1969). The present findings, combined
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with earlier observations in different countries, suggest that perimenopause is
mainly associated

with

psychosomatic

symptoms,

such

as

irritability,

forgetfulness, lack of energy, stiff joints, and headache.
No previous studies were found which used rating scales to measure the
distress

of

psychosomatic

complaints.

This

study

found

that

the

psychosomatic symptoms were most distressful in perimenopausal women. As
discussed previously, many women were bothered more by the psychosomatic
complaints for which they often did not have an explanation and for which they
sought medical care.

This is in agreement with the findings reported by

Oldenhave et al. ( 1 993) in the Netherlands and by Boulet et al. ( 1994) in seven
South-East Asian countries. According to a National Ambulatory Medical Care
Survey (NAMCS) in 1989, symptoms such as headache, neck, shoulder and
back discomfort,

depression,

dizziness, anxiety and nervousness, and

particularly tiredness, exhaustion and fatigue, were ranked in the top 36
reasons of 60 reasons for visiting physicians mentioned by women patients,
aged 45 to 64 years. This indirectly suggests that psychosomatic problems
among this age group are more distressful than vasomotor symptoms.
Sexual health
In this study, the prevalence of sexual problems were: decrease in sexual
desire 57%, vaginal dryness, 53.3%, dissatisfaction, 37.9%, and painful
intercourse, 27.6%. Yet these women did not rank these sexual problems as
highly as other perimenopausal symptoms. This is consistent with previous
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studies or commentaries (Bachman, et al., 1985; Channon and Ballinger, 1986;
Hunter, Battersby, and Whitehead, 1986) (see table 3).
The distress associated with sexual problems has seldom been studied.
This study found sexual problems were less stressful than psychosomatic and
menstrual complaints, but more stressful than vasomotor symptoms. Sexual
problems maybe overshadowed by other symptoms such as mood swings and
menstrual irregularity.

The beliefs that sexual decline and dysfunction in

perimenopausal women are the natural consequences of aging and hormonal
decline, and that women who maintain interest in sexual activity at levels
exhibited during their 20s and 30s did not seem to influence the responses
from the present sample.
Aim 2. Effect of Current Physical Activity on Perimenopausal Symptoms
Regular physical activity has long been regarded as an important
component of a healthy lifestyle. This impression has been reinforced by new
scientific evidence that physical activity prevents or reduces the incidence of
cardiovascular disease, obesity, osteoporosis, anxiety and depression (Pate, et
al., 1995).

There is beginning evidence that physical activity

may be an

important contributor to perimenopausal symptom prevention and management.
Therefore, this study was designed to examine the effect of physical activity
on perimenopausal symptoms.
Effect of current physical activity on vasomotor symptoms
The findings from the present study did not support the notion that
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physical activity ameliorates vasomotor symptoms. This is consistent with two
previous studies. Wilbur et al. ( 1992) in a study of 279 midlife women found
that physical activity measured by energy expenditure did not effect the
occurrence of vasomotor symptoms. Guthrie et al. ( 1995) in a community
study of 2000 women also found that the level of physical activity had no
significant effect on women's experience of troubling symptoms, such as
vasomotor symptoms. Thus the present study in combination with Wilbur et
al. and Guthrie et al. seem not to support physical activity as an alternative to
estrogen replacement therapy for vasomotor symptoms.
However, in contrast to these findings, Wallace et al. ( 1982) found that
short-term exercise reduced vasomotor symptoms in menopausal women.
They tested pre- and postmenopausal women before and after an aerobic
conditioning program. Fifty-five percent of the postmenopausal women reported
a decrease in severity of hot flashes and both groups showed a significant
increase in levels of estrogen. Similar to findings of Wallace et al., Hammar et
al. ( 1 990) in a study of 1 246 women found that hot flashes and sweating were
only half as common in postmenopausal women who took part in organized
physical exercise as compared to the control group.
The

differing

findings

between

the

present

study

and

those

demonstrating that exercise can help vasomotor symptoms can be explained
by several factors. First, the studies by Wallace et al. and Hammar et al. used
different study populations than the present study; while Wallace et al. and
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Hammar et al. used postmenopausal women, the present study used
perimenopausal women as subjects. The postmenopausal women's responses
to exercise may be different from those of the perimenopausal women. For
example, Wallace and colleagues found that exercise which relieves symptoms
for postmenopausal women was not useful for peri- and premenopausal
women.
The second explanation for the discrepancies in findings is that it may
require higher levels of physical activity to relieve vasomotor symptoms.

It

should be noted that the levels of activity in the studies by Wallace et al. and
Hammer et al. could have been higher than the physical activity levels in the
present study.

This may also be true of the studies by Wilbur et al.

and

Guthrie et al. The present study also showed a trend that women with higher
levels of vigorous activity experienced fewer vasomotor symptoms and less
distress. However, this difference did not reach statistical significance level.
So it is possible that the level of vigorous activity practiced by women in the
present study as well as those in the studies by Wilbur et al. and Guthrie et al.
was not high enough to have a significant effect on vasomotor symptoms.
The present study not seem to support the view that changed central
noradrenergic and opioid activity cause hot flashes (Schurz et al., 1 988;
Shoupe and Lobo, 1987; Sturdee and Brincat, 1988; Tepper et al., 1987).
Experts suggest that there are several indications of changes in both
noradrenergic and opioid neuron activities during perimenopause (Shoupe and
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Lobo, 1 987; Sturdee and Brincat, 1 988); and that P-endorphin has been shown
to increase after estrogen supplementation (Shoupe and Lobo, 1987). If low
opioid activity is involved in the mechanisms that elicit the hot flashes, then
regular physical activity, which is known to increase central opioid activity
(Cumming and Wheeler, 1987), should diminish the risk of hot flashes.
However, in this study, the occurrence and severity of the vasomotor
symptoms was the same for physically active women as for inactive women.
Again, the possible explanations include that the dose of physical activity was
not high enough to increase the central opioid activity.

Another possible

explanation might be that the active women had less adipose tissues. Adipose
tissue converts adrenal

androgens to estrogens,

perimenopausal symptoms.

which

may alleviate

In this study, levels of physical activity were

significantly correlated with body mass index, which suggest that physically
active women had less body fat.
Effect of current physical activity on psychosomatic symptoms
The present study demonstrated for the first time that moderate amounts
of physical activity may significantly decrease the occurrence and distress of
psychosomatic symptoms. The groups who participated in physical activity
had fewer symptoms than the group who were inactive.

The potential

beneficial effect of physical activity on psychosomatic symptoms is consistent
with previous studies of physical activity on mortality of cardiovascular
diseases. Pate et al. ( 1995) in reviewing several studies of physical activity on
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the relative risk of cardiovascular mortality concluded that the health benefits
of physical activity appear to accrue in approximate proportion to the

~otal

amount of activity performed, measured as either caloric expenditure or minutes
of physical activity (Blair et al., 1989; Ekelund et al., 1988; Leon et al., 1987;
Morris, et al., 1990; Paffenbarger et al., 1993; Sandvik et al., 1993).
This finding is also consistent with a number of other studies of physical
activity in menopausal women. Wilbur et al. ( 1990) found significant negative
correlations between leisure time physical activity and nervous (tiredness,
irritability, headache, nervous tension, trouble sleeping and depression) and
general symptoms (joint pain, backache, diarrhea, upset stomach, cough, et al.)
in pre-, peri-, and postmenopausal women. Collins and Landgren (1995) found
that in a Swedish population-based sample of perimenopausal women, negative
mood was associated with a lack of exercise.
However, the findings of the present study are inconsistent with one
recent study. Guthrie et al. (1995), in a random selected community cohort of
2000 Australian women, found that there were no significant associations
between levels of physical activity, psychological well-being and women's
experience of symptoms during the natural menopause transition.

The

discrepancies between the two studies may be explained by the measurement
of physical activity. In the present study, physical activity was measured as
the total amount of moderate and vigorous activity. In contrast, Guth ire et al
( 1995) measured physical activity as daily energy expenditure using the
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Minnesota Physical Activity Questionnaire which includes light, moderate, and
vigorous activity. Including the light activity may dilute the effect of moderate
and vigorous activity on perimenopausal symptoms, because light activity has
been shown to have no beneficial effects on health.
Although it appears that there is amelioration of psychosomatic
symptoms with more physical activity, there is no clear physiological
explanation for these findings. Fremont and Craighead ( 1987) suggested that
physical activity may produce increased levels of endorphins which influence
mood. Raised endorphin levels have been associated with significant reduction
in depression (Gerner et al., 1980). However, Farrell et al. (1987) found that
endophins activated by physical activity had no effect on mood alterations.
Psychological explanations for psychosomatic symptom relief after
physical activity have been the subject of several reviews (Coverley-Veale,
1987; Gieser & Mendelberg, 1990; Kirkcaldy & Shephard 1990). Cognitivebehavioral theory proposes that cognitive distortions and repeated intrusive
thoughts are major components of psychosomatic symptoms (Beck, 1987).
Physical activity may act as a distraction from intrusive thoughts, and allow
positive thoughts to surface, decreasing depression in the short-term. Another
possible explanation is that physical activity improves body image and selfefficacy which impacts on self-concept and self-esteem. The increased social
contact offered by physical activity groups may be particularly relevant.
However, much of this remains speculative. Thus, so far we can only report
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that physical activity can alleviate psychosomatic symptoms.
Although physical activity is beneficial to psychosomatic symptoms, the
effect is not dose dependent. The relatively active group experienced fewer
psychosomatic symptoms and distress than the active group. The non-linear
relationship may be due to the rigid classification of levels of physical activity.
It is also possible that some active women may have underreported their
activity and being classified into the relative active group.

Further study is

needed to identify the adequate dose of physical activity for psychosomatic
symptoms.
Effect of current physical activity on sexual symptoms
Another significant finding of this study was the negative relationship
between levels of physical activity and occurrence and distress of sexual
symptoms.

Sexual health for perimenopausal women has not been well

studied. Collins and Landgren ( 1995) found that in a Swedish population-based
sample of perimenopausal women, occurrence of perimenopausal symptoms
including reduced sexual interest was related to lack of exercise. However, no
separate analysis for sexual health was done.
It is not clear how physical activity influences sexual health. A study of
sexual behavior in exercising men indicated that sexual health was related to
the level of physical fitness (White, Case, McWhirter, & Mattison, 1990).
Physical activity can improve physical fitness, thus, help improve sexual health.
Other data suggest that orgasmic pleasure may increase with increased skeletal
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muscle tone resulting from physical activity (Mandell, 1979).

Another

explanation may be that physical activity increases women's perceived physical
attractiveness and, consequently, enhanced sexual health (Holmes, Chamberlin,
& Young, 1994).
Effect of current physical activity on menstrual problems
Menstrual problems during perimenopause have not been well studied.
In this study, no significant differences were found between the menstrual
problems reported by physically active and inactive women.
Previous research has shown that menstrual irregularity such as
oligomenorrhea or secondary amenorrhea is an infrequent but possible
consequence of strenuous exercise programs in menstruating women and is
frequently used as an argument against women engaging in strenuous exercise
(Bullen et al., 1985; Gannon, 1988). Russell et al. (1984) reported that six
swimmers who were training intensively up to five hours per day, five days per
week developed oligomenorrhea; however, all six resumed normal menses
when training was reduced. This suggests that exercise -induced menstrual
changes may be temporary.

In attempting to clarify the cause of menstrual

irregularity in athletes, Shangold, Gatz, and Thysen ( 1981) have pointed out the
necessity of separating the effects of exercise per se, from the effects of the
physical stress of training and the emotional stress of competing. Schwarz et
al. ( 1 981) found that amenorrheic runners associated more stress with their
running than did normally menstruating runners.

In the present study,

no
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relationship was found between physical activity and menstrual symptoms.
One explanation is that the physical activities of this group of women were not
strenuous enough to cause menstrual dysfunction, and without competition, no
emotional stress was involved. Thus, it may be concluded that physical activity
has a variety of beneficial effects and is not associated with potentially harmful
menstrual changes, particularly in moderate doses.
AIM 3. Effect of Long-term Physical Activity on Perimenopausal Symptoms
Long-term physical activity is defined by two independent factors-weekly amount of physical activity and years of activity performed. Both longterm and current physical activity were related to perimenopausal symptoms
in the same way. It is possible that women who are active currently have also
been active long-term. Total years of physical activity had significant effect on
perimenopausal symptoms. Women with 10 or more years of moderate and /or
vigorous activity had significantly less total, psychosomatic and sexual
symptoms than those with less than 10 years of physical activity. This finding
further supports the view that long-term physical activity is beneficial to
perimenopausal health.This finding supports the view that physical activity of
lifelong continuation is as important, if not more important than recent or short
term physical activity (Shinton and Sagar, 1993)
Additional Findings
Women experience decreased quality of life during perimenopause
compared to premenopausal stage. This finding is expected because women
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are generally experiencing more symptoms during peri- than premenopausal
period. Experience of symptoms such as hot flashes and forgetfulness and the
distress

caused

by them

would

decrease the

quality

of

life

during

perimenopause.
All

aspects

of perimenopausal

symptoms

except occurrence of

vasomotor symptoms are significantly correlated with quality of life. However,
using multiple regression analysis, it was found that psychosomatic symptoms
were the single significant symptom category among the four subscales
predicting quality of life. The occurrence of psychosomatic symptoms as a
single factor accounted for 32% of the variance. This indirectly suggests that
psychosomatic symptoms are important determinants to quality of life in
perimenopausal women.
Finally, the more active the woman, the better quality of life. This can
be explained by the fact that physical activity reduces psychosomatic
symptoms,

the most prevalent and distressful

symptoms,

among the

perimenopausal women which lead to better quality of life.
Conclusions, Implications and Limitations
In conclusion, perimenopausal symptoms were reported to occur rarely
to sometimes and, for the majority of women, symptoms were a little
distressful in a community-based population.

Among these symptoms,

menstrual problems, such as excessive bleeding, were most prevalent, followed
by psychosomatic,

sexual,

and vasomotor symptoms.

However, the
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psychosomatic symptoms, such as lack of energy, forgetfulness, irritability,
were the most distressful, compared to menstrual, sexual, and vasomotor
symptoms. Vasomotor symptoms were the least frequently experienced and
least distressful symptoms among four group of symptoms.

This seems

contradictory to contemporary health care view that women often seek help for
vasomotor symptoms.

It is possible that somen women with vasomotor

symptoms may have been excluded from this study due to treatment with
hormone replacement.
The findings from this study suggest that physical activity is beneficial
to psychosomatic symptoms. Although the effect is not dose dependent, both
relatively active and active group had fewer psychosomatic symptoms than
inactive. No relationships were found between vasomotor symptoms and the
amount of physical activity, thus these findings do not support the use of
physical activity as an alternative to hormone replacement therapy for
vasomotor symptoms. This is of practical and consistent with public health
value for perimenopausal women, for whom the issue of moderate physical
activity is of greater interest. Long-term physical activity was also beneficial
to psychosomatic symptoms.
All

perimenopausal

symptoms

except

occurrence

of

vasomotor

symptoms were significantly correlated with quality of life. The frequency of
psychosomatic symptoms was the single significant symptom category
predicting quality of life in perimenopausal women.
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One third of this group of perimenopausal women was inactive, which
suggests that more efforts are needed to change this sedentary population into
an active one. African American and other ethnic minority women were less
active than white Americans, and women who were widowed, separated, or
divorced tended to have less long-term vigorous physical activity, and working
women reported physical activity.

Special efforts will be required to target

these populations in which physical inactivity is particularly prevalent.
The present results provide systematic evidence of a relationship
between physical activity and some perimenopausal symptoms.

This study

therefore increases basic knowledge of perimenopausal symptoms and physical
activity by identifying the relationships between the two factors.

This

conclusion is likely to be welcome news, especially for those women who wish
to reduce some perimenopausal symptoms using nonpharmacological methods.
It can also increase the confidence of those women who want to change from
a sedentary to an active life style, in efforts to reduce risk of bone loss and
cardiovascular disease.
Unique educational opportunities exist when women can be informed of
practical methods to reduce psychosomatic symptoms which were the most
prevalent and most distressful to women in this study. With the information
gained here, nursing interventions to promote physical activity can be tailored
to reduce some perimenopausal symptoms. Information from this study can
also lend an awareness of, and appreciation for, the relationship between
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perimenopausal symptoms and physical activity.
However, conclusions must be qualified in recognition of the study's
limitations. Only 214 perimenopausal were investigated. In addition, some
candidates in the available pool were excluded for the reasons given in
Methods, thus further limiting generalizations. The differences between the
respondents and non-respondents may have influenced our results, as the
respondents had a higher level of education, which probably influenced their
levels of physical activity. Lack of participation in recreational physical activity
was more common in less well educated women. An improved techniques of
data collection are needed to obtain higher responds rate.
Future Research Recommendations
This study was designed to examine the frequency and distress
associated with symptoms experienced by perimenopausal women, and their
relationship to physical activity using a cross-sectional design. Four groups of
symptoms were experienced by perimenopausal women. Further research is
needed to identify the relationship between these symptoms and menopausal
status over time, from pre- to postmenopausal periods. A longitudinal design
will help gain an understanding of how these symptoms behave over time. This
would also provide opportunity to examine hormonal changes.
Associations between the amount of physical activity

and two

dimensions of psychosomatic and sexual symptoms in perimenopausal women
were also noted, however there was no compelling evidence to support a
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conclusion

that

physical

activity

was

causally

related

psychosomatic and sexual health in these women.

to

enhanced

A well-controlled,

longitudinal study is needed to clarity the causal relationships between physical
activity and perimenopausal symptoms.
Further study should investigate whether the relationships between
physical activity and perimenopausal symptoms is also true in postmenopausal
women.

There is also a need to further clarify the relationships between

physical activity and vasomotor symptoms. Women who participate in exercise
programs may be used to study these

relationships, offering a clearer

understanding of the importance/nonimportance of physical activity and its
influence on vasomotor symptoms during the transition into menopause.
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APPENDIX A.
HORMONAL ASPECT OF PERIMENOPAUSE
Author/ Title

I Sample

Variables/
Instruments

Findings

Longcope, Franz,
Morello, Baker,
& Johnston,
( 1986). Steroid
and
gonadotropin
levels in women
during the perimenopausal
years.

n=88; aged
45-58 yrs

blood samples
were obtained
every 1-2 month
and analyzed for
estrogens,
androgens and
gonadotropin
using
radioimmunoassay
techniques

There is a gradual decline in ovarian estrogen secretion
during the perimenopause. In most women, this gradual
decline is not associated with episodes of vaginal bleeding,
despite levels of estrogens which are capable of
endometrial stimulation. There is a significant inverse
correlation between estrogen and FSH concentrations.

Trevoux, Brux,
Castanier,
Nahoul, Soule, &
Scholler (1986).
Endometrium
and plasma
hormone profile
in the perimenopause and
postmenopause

n=483;
Longitudinal
study over a
period of 13
years

Endometrial
histology and
plasma levels of
Follicle Stimulating
Hormone (FSH),
Lutealizing
Hormone (LH),
Estradiol (E2),
Estrone (E 1) and
Progesterone (P).

From Year-6 to year-3, gonadotrophin levels increased
gradually while those of E2 remained normal, with peaks in
some cases. Mean plasma P levels were within the normal
range until year-3, but they then decreased progressively.
From Year-3 to year+ 1 there was a concomitant rise in
gonadotrophin as the E2 and P levels decreased. However,
at the start of definitive amenorrhea, the mean E2 and P
levels fluctuated between 60 and 100 pg/ml and between
2 and 3 ng/ml, respectively. The endometrium was
proliferative rather than atrophic. From year+ 1 to year+ 7,
gonadotrophin reached a plateau at high levels while those
of E2 continued to fall, reaching very low values at
year+ 4, after which they reached a plateau. P levels were
at the detection limit of the technique.
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APPENDIX A (cont.)
Richardson,
Senikas, &
Nelson, (1987).
Follicular
depletion during
the menopausal
transition:
evidence for
accelerated loss
and ultimate
exhaustion.

n=17
women aged
45-55 yrs.
(pre= 6,
peri = 7,
post= 4).

Follicle numbers in
one ovary from
each woman.

The mean number of primordial follicles in the ovaries of
premenopausal women was 10-fold higher than that in
perimenopausal women. Follicles were absent in
postmenopausal women. It was concluded that declining
follicular reserve was the immediate cause of
perimenopause.

Shideler,
DeVane, Kalra,
Benirchke, &
Lasley, (1989).
Ovarian-pituitary
hormone
interactions
during the
perimenopause

n=5;
women aged
42-47 yrs
(pre =3;
peri = 2).

1 . Daily urine and
random blood
samples collected
for 3 or 4
consecutive
cycles. 2. Estrone
measured by urine.
3. LH, FSH, P, E1,
E2 measured using
serum samples.

There are some forms of menstrual variability at the time of
the perimenopause associated with lowered early follicular
phase estrogen levels. Reduced negative feedback and
subsequently increased gonadotrophin levels may have
stimulated estrogen production which may have
suppressed gonadotrophin secretion and lowered estrogen
excretion.
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Hee,
MacNaughton,
Bangah, &
Burger, (1993).
Perimenopausal
patterns of
gonadotrophin,
immunoreactive
inhibin,
oestradiol and
Progesterone

n=10
(pre= 7 aged
34-44;
peri =3 aged
45-46).

Radioimmunoassay
of serum FSH, LH,
E2, P.

Perimenopausal women have lower levels of E2 and P than
premenopausal women but higher levels of E2 and P than
postmenopausal women.
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APPENDIX B.
AGE AND THE DURATION OF PERIMENOPAUSE

Author/year

Sample

Design

Variables/
instruments

Findings

Comments

Magursky,
Mesko, &
Sokolik, 1975

6877 women
aged 38-58 yrs.

Crosssectional
survey

Age of
menopause, age
and duration of
perimenopause
and factors
influence onset
and duration of
perimenopause
measured by selfconstructed
questionnaire that
consisted of 25
questions.

The mean age at the
menopause was 51 yrs.
The mean age at the onset
of the perimenopause was
47.6 yrs. Women with
menstrual disturbances had
their menopause about 1 yr
earlier. Age at menarche
and parity had no effect on
the age at the onset of
perimenopause. Women
working in agriculture and
house-wives had their
menopause a little later
than mean age of the
sample, whereas manual
workers and those in other
occupational categories
had their menopause and
onset of the
perimenopause about 1
year earlier.

Retrospective

.....
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APPENDIX B (cont.)
Treloar, 1981

n=291 women

All women
were
followed
from the
time of
menarche to
menopause.

Menstrual history
measured by selfconstructed
questionnaire.

The age for the onset of
perimenopause was 45.5
years, with a range of 34
to 55 yrs. The duration of
perimenopause was 4.8 yrs
with a range of 1 to 10
years. The cyclic variability
may be indicative of
duration of the
perimenopause.

McKinlay,
Brambilla, &
Posner, 1992

N = 1178
premenopausal
women, aged
45-55 yrs.

Longitudinal
study.
Women
were
followed for
5 yrs by
telephone
interviews
with 9month
intervals.

Menopausal
status,
demographics,
and a list of 22
signs/symptoms

The median age at
inception of perimenopause
is 47.5 yrs and the
duration is about four
years. Smokers tend to
have an earlier and a
shorter perimenopause.
Only the vasomotor
symptoms are related to
menopausal status.

No
psychometric
parameters
reported on
tools used.
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APPENDIX C.
PREVALENCE OF SYMPTOMS DURING PERIMENOPAUSE (%)

Author /year

Menopausal
status

Vasomotor

Jaszmann et
al. (1969)

pre
peri
post

17
40
35

McKinlay et
al. (1992)

pre
peri
post

10
50
20

Hunter
(1992)

pre
peri & post

24
45

13
21

27
40

Matthew et
al. (1992)

pre
peri & post

6
43

19
9

7
14

Kaufert et al.
(1992)

pre
peri
post

26
26
26

Avis et al.
(1993)

pre
peri
post

14
37
33

Depression

Fatigue

Irritability

46
55
<50

35
15

Sleep
disturbance

Sexual
disturbance

Mood change

20
40
30

27
40

29
38
34

I-'
I-'
I-'

APPENDIX C (cont.)

Koster &
Davidsen
(1993)

pre
peri
post

31
46
68

12
21
16

21
30
26

Dennerstein
et al. ( 1993)

pre
peri
post

10
31
39

25
33
29

38
46
38

Shaver &
Paulsen
(1994)

pre
peri
post

33
34
32

32
41
40

24
35
41

43
53
64

Note: Empty box = Observations not made or reported.
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APPENDIX D.
THE RELATIONSHIP BETWEEN MENOPAUSAL STATUS AND SYMPTOMS REPORTED DURING MIDLIFE
Author/year

Sample

Design

Variables/
instruments

Findings

Comments

McKinlay et
at., 1992

N = 1178 women,
aged 45-55 yrs.

Longitudinal study.
Women were
followed for 5 yrs.
by telephone
interview with 9month intervals.

Menopausal status,
demographics, and
a list of 22
signs/symptoms

The median age at
inception of
perimenopause is 4 7. 5
yrs and the duration is
about four years.
Smokers tend to have
an earlier and a shorter
perimenopause. Only
the vasomotor
symptoms are related
to menopausal status.
The relationship
between
perimenopause and
symptoms reporting
seems to be transitory,
with reported rates
showing an increase in
the perimenopause and
a compensatory
decrease in the
postmenopause.
Women with longer
perimenopause have
more symptoms.

No
psychometric
parameters
reported on tool
measuring
symptoms used.

1--'
1--'
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APPENDIX D (cont.)
Matthew et
al., 1990

n = 541 initially
premenopausal
women aged 4250 yrs. After 3
years of followup, pre= 101 and
post=69.

1 . Longitudinal
design. 2. All
women were
followed for 3 yrs.
3. Premenopausal
women (n = 101 )
were evaluated at
baseline and 3 yrs
later;
postmenopausal
women were
evaluated at
baseline and within
three months after
their diagnosis of
postmenopause.

1 . Menopausal
status. 2. Physical
and psychological
symptoms
experienced during
the previous 2
weeks measured by
a standard checklist
of 27 symptoms
(Neugarten
&Kraines, 1964);
psychosocial
factors measured
by inventory
containing
standardized
personality tests of
psychological
factors.

Vasomotor symptoms
were significantly
correlated with
menopausal status.
There were few
changes in
psychological
characteristics.

Sample size was
relatively small
compared with
the complex
analyses (Total
of nine scales
were used to
measure the
psychosocial
status).

Kaufert et al.,
1988

n = 4 77 initially
premenopausal
women aged 4555 yrs

Longitudinal design.
All women were
interviewed 6 times
over a 3-yr period.

1 . Menopausal
status. 2.
Symptoms
measured by a
checklist of
physical,
menopausal , and
psychological
symptoms.

There was a significant
relationship between
vasomotor symptoms
and menopausal
status; there was no
significant relationship
between psychological
symptoms and
menopausal status.

No
psychometric
data reported on
the tool
measuring
symptoms.

......
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APPENDIX D (cont.)
Hunter, 1 990

n=36
premenopausal
women aged 45
to 55 yrs

Prospective and
longitudinal design.
Women were
interviewed at
baseline and 3
years later

1 . Menopausal
status
2. Women's Health
Questionnaire
(WHO) (total of 28
items)

Vasomotor symptoms
and depressed mood
were significantly
correlated with
menopausal status;
other psychological
and sexual symptoms
were not.

Small sample
size.

Jaszmann et
al. 1969

n = 2906 women
(pre=999;
peri =804;
post= 1103)

Cross-sectional
survey (postal
questionnaire)

1 . Menopausal
status. 2.
Symptoms
measured by Blatt
Menopausal Index.

All kinds of symptoms
were more prevalent in
peri- and
postmenopausal
women.
Premenopausal women
have significantly less
vasomotor symptoms.

Premature
menopausal
women were
included in their
sample which
limited the
generalization of
the study
results.

Holte &
Mikkelsen,
1991

n = 2349 women
aged 45-55 yrs
were surveyed.
n = 1686 women
(pre=765,
peri =88,
post= 833) used
in analysis.

cross-sectional
survey (postal
questionnaire)

1 . Menopausal
status. 2. Symptom
checklist composed
of 24 items

Vasomotor complaints
and vaginal dryness
were the only variables
significantly related to
menopausal
development.

The reliability
and validity of
the tools used
were not
reported.

......
......
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APPENDIX D (cont.)
VanHall et
al., 1994

n = 8679 women
and men aged 2574.
(women= 4426,
men=4253).

Cross-sectional
design. Personal
health interview.
Subjects were
divided into 6
groups according to
their ages rather
than menopausal
status.

1 . Menopausal
status.
2. Questions related
to a variety of
complaints
experienced during
the past two
weeks. 3.
Psychosomatic
symptoms
measured by
General Health
Questionnaires
(GHQ) and
Biographic Problem
List (BIOPRO) were
also delivered.

Except for excessive
perspiration, none of
the other complaints
usually attributed to
menopause increased
more in women than in
men during the
perimenopausal period.
It was concluded that
psychosomatic
complaints usually
attributed to the
climacteric are neither
gender nor age specific
and that, therefore, a
hormonal cause for
these complaints
seems unlikely.

Standardized
three stage
definitions were
not utilized.
Women were
divided into
groups
according to
their age instead
of menopausal
status

I-'
I-'
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APPENDIX D (cont.)
Koster &
Davidsen,
1993.

n=597 women
aged 51 years.
(pre=47,
peri =91,
post= 129,
hormone
group= 125,
surgical
menopause= 84)

Cross-sectional and
retrospective for
past 4 years.
Postal questionnaire

1 . Menopausal
status. 2.
symptoms related
to menopause. 3.
significant life
events

Prevalence of hot
flashes, moodiness and
fatigue were
significantly associated
with menopause
status. However,
fatigue, moodiness and
depression were more
strongly associated
with socioeconomic
variables than
menopause status.
Sexual desire was not
correlated with
menopausal status.

1 . Bias due to
retrospectivity
for four years.
2. Relatively
small sample of
natural
menopausal
women. 3.
Questionnaires
were
constructed by
the researchers.
The reliability
and validity of
tools were
unknown.

~
~
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APPENDIX D (cont.)

Shaver &
Paulsen,
1993

n = 135 women
aged 37-59 yrs.
(pre and good
sleep (GS)= 30,
pre and poor
sleep( PS)= 23,
peri and GS= 20,
peri and PS= 23,
post and GS= 14,
post and PS= 25).

Cross-sectional
design. Sleep
quality and
psychological stress
were compared in
two groups of
menopausal women
(divided by the
presence of the
sleep disturbance)

1 . Menopausal
status 2. Selfreported sleep
quality using a 4point scale in a
daily health diary.
3. Objective sleep
pattern measured
by the time to fall
asleep from lights
out to each stage of
sleep and percent of
time spent in each
sleep stage and
three summary
indexes. 4.
Psychological stress
was measured by
Symptoms
Checklist 90
(Derogatis, 1977)

More than one-third of
the midlife women
reported poor sleep
quality. But
menopausal status and
perceived sleep quality
were not statistically
related. Women with
poor sleep reported
higher levels of
psychological distress
and somatic symptoms
than women reporting
good sleep.

.......

.......
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APPENDIX D (cont.)
Avis et al.,
1993

Three groups of
women from
different cultures
were studied.
Samples included
8050 U.S.
women aged 4555 yrs, 1326
Canadian women
aged 40-59 yrs,
and 1316
Japanese women
aged 45-55 yrs

Cross-sectional
survey using mailed
questionnaire

1 . Menopausal
status. 2.
Symptoms
measured by a
questionnaire
(adapted from
Kaufert & Syrotuik,
1 981 ) consisted of
16 symptoms. 3.
Medication use
measured by selfconstructed
questions

1. Women in the US
are likely to begin
experiencing
menopause at an
earlier age than
Japanese or Canadian
women. This may be
due to the effect of
smoking on age of
menopause. 2.
Japanese women,
compared with
Northern American
women, report
generally lower rates of
a wide range of
symptoms and
commensurately low
rates of medication
use. 3. For the
symptoms and
medications
considered, there is no
or only a weak
association between
reported use and
menopause status in
Japanese women. 4.
The association
between menopause
status and symptom or
medication reporting
was quite variable.

Confounding
variables (such
as lifestyle and
genetic factors)
may influence
the
comparability of
the study result.

......
N
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APPENDIX D (cont.)
Hunter et al.,
1986.

n=682 women
aged 45-65
(pre= 124,
peri = 177, and
post=380).

Cross-sectional
survey using postal
questionnaire.

1 . Menopausal
status. 2.
Symptoms
measured by
Women's Health
Questionnaire. 3.
Social factors and
general health
measured by
Pilowsky
Hypochondriasis
Questionnaire
(1967)

Vasomotor symptoms,
depressed mood, and
sexual difficulties were
best predicted solely
by menopausal status
while other
psychosomatic
symptoms were more
clearly associated with
psychosocial factors.

I-'

N
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APPENDIX E.
THE RELATIONSHIP BETWEEN PHYSICAL ACTIVITY AND SYMPTOMS REPORTING IN MIDLIFE

I

Author /year

Sample

Design

Variables/
instruments

Findings

Wilbur et al.,
1992

n=279 women
aged 37 to 64
yrs

The original study
was a longitudinal.
This report only
concerned the
results from a
cross-sectional
data.

1 . Menopausal
status. 2. A 12month energy
expenditure
measured by selfreport
questionnaire. 3.
Symptoms
measured by the
21-item Kaufert and
Syrotuik Symptoms
Index.

Perimenopausal
women had the
highest scores on
symptoms than pre,
post, and surgical
menopausal women.
Premenopausal group
had the lowest scores
for vasomotor
symptoms. There was
a significant positive
relationship between
occupational energy
expenditure and
vasomotor symptoms
and general health.
However, there was a
negative correlation
between leisure time
energy expenditure
and overall symptoms
reporting.

Comments

......
N

w

APPENDIX E (cont.)
Wallace et
al., 1982

n= 11 women,
mean age of
pre= 43 yrs, and
mean age of
post=53.7 yrs

Longitudinal design

1 . Menopausal
status. 2. Estrone
(E1), Estradiol (E2)
& androgens
measured by
radioimmunoassay.

Both pre- and
postmenopausal
women significantly
increased level of E2.
The E1 and E2 profile
in postmenopausal
women changed to
premenopausal level.
Severity of flashing
changed in 55% of
postmenopausal
women. Exercise
therapy appears to
change symptoms
during postmenopausal
period

Sample size was
too small for
adequate
analyses. It was
not clear how
many women
were
premenopausal
and how many
were
postmenopausal.
In addition, it is
not clear what
kind of exercise
program was
applied to midlife
women.
Perimenopausal
women as a
group were not
studied.

,_.
N

-!:'-

APPENDIX F.
QUESTIONNAIRE BOOKLET

125

126
APPENDIX F.
QUESTIONNAIRE BOOKLET

ID
Date

A Study of Women's Health

Suling Li, MSN, RN
PhD Candidate
Loyola University Chicago
Office at the Loyola University Medical Center
2160 First Ave
Building 105, RM 2840
Maywood, Il 60153
Tel (708) 216-9577

APPENDIX F (cont.)

DEMOGRAPHIC QUESTIONNAIRE

I.

What is your social security number

2.

What is your current age?

3.

What is your race (Please circle only one)

_ _ (yrs)

Caucasian . . . . . . . . . . . . . . . . . . .
Black . . . . . . . . . . . . . . . . . . . . .
Hispanic . . . . . . . . . . . . . . . . . . .
Asian . . . . . . . . . . . . . . . . . . . . .
American Indian/Alaskan Native . . .
Pacific Islander . . . . . . . . . . . . . . .
Other (specify) . . . . . . . . . . . . . . .

- - -feet

2
3
4
5
6
7

4.

What is your height?

5.

How much do you weigh _ _(lbs)

6.

How many years of school have you completed so far?
Less than 7th grade . . . . . . 1
7 thru 9th grade . . . . . . . . . 2
Partial high school
(! 0-11 th grade) . . . . . . . . . 3
High school grad . . . . . . . . 4
Partial college . . . . . . . . . . 5
College grad . . . . . . . . . . . 6
Grad/Prof training . . . . . . . 7

inches
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7.

Are you currently working at a job for pay?
No ....... 0
Yes . . . . . . 1
7a:

If yes, do you work full time or part time?

Full time
Part time ............. 2

7b:

8.

If you are working, what is your occupation

What is your current marital status? (Please circle only one)
Never married . . . . . . . . . . 1
Married . . . . . . . . . . . . . . 2
Married but separated . . . . . 3
Divorced ............. 4
Widowed ............. 5
Other (Please specify)
~~~~~~~~

9.

Which socio-economic level do you feel you belong to at the present time?
Lower . . . . . . . . . . . . . . . 1
Middle ............... 2
Upper. . . . . . . . . . . . . . . . 3

I 0.

What was your household income, before ta"{es last year?
less than $5,000 . . . . . . . . . 1
$5.000to$19,999 ....... 2
$20,000 to $39,999 . . . . . . 3
$40,000 to $59,999 . . . . . . 4
$60,000 to $79,999 . . . . . . 5
$80,000 to $99,999 . . . . . . 6
$100,000ormore ....... 7
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WOMEN'S HEALTH ASSESSMENT
This questionnaire is about the body changes and symptoms occurring during midlife
and associated with perimenopause/menopause.
This questionnaire asks what
perimenopausal/menopausal symptoms you are currently experiencing or have
experienced during the past year and how bothersome they are to you.
NOTE: THIS QUESTIONNAIRE IS NOT ABOUT SYMPTOMS !<ELATED TO ANY CHRONIC CONDITIONS
YOU MAY HAVE (For example, chronic backaches, chronic asthma).
DIRECTIONS: The left column lists a variety of symptoms. Please read each symptom
carefully and rate the frequency of the symptom in the middle column (Part A),
0
1

2
3
4

never had,
rarely,
sometimes,
often,
always

and then how bothersome in the right column (Part B),
0
1
2
3
4

not at all,
a little,
moderately,
quite a bit,
extremely.

Complete both columns before going on to the next symptom.
the symptom, you only need to complete Part A.

If you never experience

EXAMPLE: Ms. Smith (47 years old) has experienced DIZZY SPELLS sometimes which are
quite bothersome and COLD SWEATS rarely which are not bothersome at all, but she
has never experienced HOT FLASHES during the past year.
Symptom

Part A
Have you experienced
this symptom during
PERIMENOPAUSE (around
menopause)?
0 = never had,
1 = rarely,
2 = sometimes,
3 = often,
4 = always

Part B
If you have experienced
this symptom during
PERIMENOPAUSE, how
bothersome was it?
0 = not at all,
1 = a little,
2 = moderately,
3 = quite a bit,
4 = extremely.

1.

hot flashes

0

1

2

3

4

0

1

2

3

4

2.

cold sweats

0

1

2

3

4

0

1

2

3

4

3.

dizzy spells

0

1

2

3

4

0

1

2

3

4
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----------------------------- ....------------------------- ....--------------------------!

Symptom

1
I

I
I
I
I
I
I

I
I

I
I

I
I

I
I
I
I
I

I

Part A
Have you experienced
chis symptom during
PERIMENOPAUSE (around
menopause)?
never had,
l
rarely,
2
sometimes,
3
often,
4
always

1

Part B
If you have experienced
this symptom during
PERIMENOPAUSE, how
bothersome was it?
0
not at all,
l
a little,
2
moderately,
3
quite a bit,
4
extremely.

------------------------------+--------------------------+--------------------------1.

!
I
I
I
I

hot
flashes/flushes

1

0

I

234

I
I
I
I

0

:

O

2

1

4

3

------------------------------+--------------------------+--------------------------2.

cold sweats

1

O

I

2

3

4

I

1

2

3

4

------------------------------+--------------------------+--------------------------3.

dizzy spells

1

O

I

2

3

4

:

1

O

I

2

3

4

------------------------------+--------------------------+--------------------------4.

lack of energy

:

1

O

I

2

3

4

1

O

I

2

3

4

------------------------------+--------------------------+--------------------------5.

- diarrhea or
constipation

1

0

2

3

I
I

4

0

l

2

4

3

:

1

------------------------------+--------------------------+--------------------------6.

irritability

I

o

1

2

3

4

:
I

o

l

2

3

4

------------------------------+--------------------------+--------------------------?.

persistent cough

I

0

1

2

3

4

:
I

O

l

2

3

4

------------------------------+--------------------------+--------------------------8.

!
1

restlessness

I

0

1

2

3

4

I

O

1

2

3

4

------------------------------+--------------------------+--------------------------9.

!

backaches

1
I

0

1

2

3

4

I

0

1

2

3

4

------------------------------+--------------------------+--------------------------10.

!

nervous tension

1
I

O

l

2

3

4

I

O

1

2

3

4

------------------------------+--------------------------+--------------------------11.

I

aches and
stiffness in
joints

I
I
I

0

1

2

3

4

:

0

1

2

3

4

1

------------------------------+--------------------------+--------------------------12.

:'

upset stomach

0

l

2

3

4

1

O

1

2

3

4

------------------------------+--------------------------+--------------------------13.

headaches

'
1
I

O

1

2

3

4

I
1
I

0

1

2

3

4

------------------------------+--------------------------+--------------------------14.

rapid heart beat

:'

O

l

2

3

4

:I

O

1

2

3

4

------------------------------+--------------------------+--------------------------15.

shortness of
breath

'
IQ
I
I
I

1

234

I
I
I
I
I

0

1

2

3

4

------------------------------+--------------------------+--------------------------'

I

1
2
4
0
3
ea~ly.morning
:
O
1
2 3 4
:
waKening
: _________________________ ..J..
: ___________________________ _
_____________________________
..J..
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-----------------------------..,--------------------------..,---------------------------Part A
Have you experienced
this symptom during
PERIMENOPAUSE (around
menopause)?
0
never had,

Symptom

l

r-arely,

2
3
4

sometimes,
often,
always

Part B
If you have experienced
this symptom during
?ERIMENOPAUSE, how
bothersome was it?
o
not at all,
a. l.:.ttle

1

moderately,
quite a bit,
extremely.

2
3
4

------------------------------+--------------------------+--------------------------sore throat or
cold

17.

1

0

2

3

I
I
I
I

4

I

1

0

2

3

4

------------------------------+--------------------------+--------------------------"pins and needles"
in hands or feet

18.

2

1

0

I
I
I
I

4

3

I

1

0

2

3

4

------------------------------+--------------------------+--------------------------leaking of urine
when laughing or
coughing

19.

2

1

0

I

4

3

I

2

1

0

3

4

I
I

:

1

------------------------------+--------------------------+--------------------------20.

•

loss of appetite

O
I

1

2

3

4

:

1

O

I

2

3

4

------------------------------+-----------~--------------+--------------------------21.

fluid retention

I

O

1

2

3

II

0

'

0

4

1

2

3

4

------------------------------+--------------------------+--------------------------22.

forgetfulness

I

0

1

2

3

4

I
I

1

2

3

4

------------------------------+--------------------------+--------------------------23.

difficulty
concentrating

0

1

2

3

I
I
I
I

4

I

0

1

2

3

4

------------------------------+--------------------------+--------------------------24.

bladder infection

II

0

'
1

O

1

2

3

4

:

I

O

1

2

3

4

------------------------------+--------------------------+--------------------------25.

loss of interest
in things

1

2

3

I
1

4

:

0

1

2

3

4

:

I

I

------------------------------+--------------------------+--------------------------26.

lack of enjoyment

I

o

1

2

3

4

:
I

O

1

2

3

4

------------------------------+--------------------------+--------------------------27.

miserable and sad

:
I

o

1

2

3

4

:
I

o

1

2

3

4

------------------------------+--------------------------+--------------------------28.

decreased feelings
of well-being

!

1

O

1

2

3

4

:

I

1

O

1

2

3

4

:

I

I

------------------------------+--------------------------+--------------------------29.

life not worth
living

'
1

O

1

2

3

4

:

I
1

O

l

2

3

4

:

I

I

------------------------------+--------------------------+--------------------------3 o.

frightened
/panicky feelings

'

1

:
I

O

1

2

3

4

I

1

O

1

2

3

4

:
I

-----------------------------....1...-------------------------....1...---------------------------
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-----------------------------..,..-------------------------..,..--------------------------'1
Part A
: Have you experienced
: this symptom during
: PERIMENOPAUSE (around
:
menopause)?
1
never had,
0
/
1
rarely,
:
2
sometimes,
:
3
often,
:
4
always

Symptom

1I
Part B
: If you have experienced
I this symptom during
PERIMENOPAUSE, how
:
bothersome was it?
/
1
0
not at all,
I l
a little,
2
moderately,
:
3
quite a bit,
:
4
extremely.
:

------------------------------+--------------------------+--------------------------31.

anxiety leaving
house alone

l

0

2

3

I
I
I
I

4

I

0

2

1

3

4

------------------------------+--------------------------+--------------------------32.

difficulty falling
asleep

:
:

0

1

2

3

4

:
:

0

1

2

3

4

------------------------------+--------------------------+--------------------------33.

breast tenderness

I

1

O

2

3

4

:

I

0

l

2

3

4

------------------------------+--------------------------+--------------------------34.

bloated stomach

:
I

0

l

234

I

0

1

2

3

4

------------------------------+--------------------------+--------------------------35.

abdominal cramps

I

0

1

234:
I

0

l

2

3

4

------------------------------+--------------------------+--------------------------36.

'
IQ
I
I
I

1

:

1

feeling
unattractive

I
I
I
I
I

234

0

l

2

3

4

------------------------------+--------------------------+--------------------------37.

clumsiness

I

O

2

3

4

I

0

1

2

3

4

------------------------------+--------------------------+--------------------------38.

not lively or
excited

0

1

2

3

I
I

4

0

1

2

3

4

I
I

I

------------------------------+--------------------------+--------------------------39.

scanty or
infrequent
menstrual flow

0

1

2

3

4

I

I

I
I
I
I
I

0

I
I
I
I
I

0

l

2

3

4

------------------------------+--------------------------+--------------------------40.

irregular
menstrual flow

'
I
Q
I
I
I

l

0

l

234

1

2

3

4

------------------------------+--------------------------+--------------------------41.

deficient amount
of menstrual flow
but periods are
regular

2

3

4

I
I
I

0

1

2

3

4

I
I

I
I
I

I

------------------------------+-------------~------------+--------------------------42.

excessive bleeding
ac the time of a
menstrual period,
either in number
of days or amount
of blood or both

O

l

2

3

4

I

O

l

2

3

4

:
:
:
1
I

:
I

-----------------------------...l..-----~-------------------...l..---------------------------
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------------------------------r--------------------------r--------------------------1

I
1

1
Part A
: Have you experienced
1
this symptom during
PERIMENOPAUSE (around
menopause)?
0
never had,
rarely,
1
2
sometimes,
often,
3
4
always

Symptom

1

Part B
If you have experienced
this symptom during
PERIMENOPAUSE, how
bothersome was it?
0
not at all,
1
a little,
2
moderately,
3
quite a bit,
4
extremely.

------------------------------+--------------------------+--------------------------43.

bleeding from the
uterus at any time
other than during
the.menstrual
pen.od

O

1

2

3

!

4

:

1

O

2

3

4

1

:
:

I

1

------------------------------+--------------------------+--------------------------44.

vaginal dryness

I

0

1

2

3

4

:

1

O

I

2

3

4

------------------------------+--------·-------------------+--------------------------45.

decrease in sexual
desire/interest

0

1

2

3

I
I
I
I

4

I

0

1

2

4

3

------------------------------+--------------------------+--------------------------46.

!
I
I
I
I
I
I
I
I
I
I
I

painful
intercourse (if
you are not
sexually active,
please skip this
row)

0

l

I

234

I
I
I
I
I
I
I
I
I
I
I

0

1

2

3

4

------------------------------+--------------------------+--------------------------47.

dissatisfaction
with sexual
relationship (if
you are not
sexually active,
please skip this
row)

!

IQ

I
I
I
I
I
I
I
I
I
I
I
I

1

234

I

I

I
I
I
I
I
I
I
I
I
I
I
I

0

1

2

3

4

------------------------------+--------------------------+--------------------------48.

other (specify) :

0

1

2

3

4

I

!
I
I
I
I
I
I
I
I
I

0

1

2

3

4

------------------------------+--------------------------+---------------------------49.

other (specify):

0

1

2

3

4

!

I
I
I
I
I

I
I
I
I

0

1

2

3

4
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QUALITY OF LIFE DURING PERIMENOPAUSE

Perimenopause is defined as experiencing irregular periods or no period for 3 to
11 months.

...

How do you rate your overall quality of life BEFORE EXPERIENCING
PERIMENOPAUSE? Please circle a number from 1 to 10, with 1 meaning that
your quality of life has been very poor and 10 meaning that your quality of
life has been very good.

'

1

2

3

4

5

6

7

8

9

very poor
quality of life
2.

10
very good
quality of life

How do you rate your overall quality of life right now? Please circle a
number from 1 to 10, with 1 meaning that your quality of life has been very
poor and 10 meaning that your quality of life has been very good.
1

2

very poor
quality of life

3

4

5

6

7

8

9

10
very good
quality of life
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LONG-TERM PHYSICAL ACTIVITY QUESTIONNAIRE
DIRECTIONS: Please circle the number or mark the appropriate box to answer each
question. In some instances it will be necessary to fill in blanks with further
information.
P1.

DURING THE PAST YEAR, HOW OFTEN DID YOU PARTICIPATE IN VIGOROUS
PHYSICAL ACTIVITIES such as, dance, basketball, gymnastics, running,
aerobics, or field hockey, briskly walking uphill or with a load, fast or racing
cycling ( > 10 mph), fast treading or crawl swimming, stair ergometer, ski
machine conditioning exercise, single tennis, racketball, fishing in stream,
rapidly canoeing ( > 4 mph), moving furniture, mowing lawn (hand mower)?
(PLEASE CIRCLE ONLY ONE CHOICE WHICH BEST DESCRIBES YOUR
ACTIVITY STYLE)
daily . . . . . . . . . . . . . . . . . . . .
4-6 times per week . . . . . . . . .
2-3 times per week . . . . . . . . .
one time per week . . . . . . . . . .
1-3 times per month . . . . . . . .
never . . . . . . . . . . . . . . . . . . .

1
2
3
4
5
6

If you practice any VIGOROUS activity, ON AVERAGE, state how many minutes do
you do VIGOROUS activity on a single time? (_)
P2.

If you have practiced the VIGOROUS physical act1v1ty style you described
above for more than one year, then specifically state how many years?
(
) YEARS
Please describe your VIGOROUS activities:
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DURING THE PAST YEAR, HOW OFTEN DID YOU PARTICIPATE IN MODERATE
PHYSICAL ACTIVITIES such as briskly walking (3-4 mph); Cycling for pleasure
or transportation ( < 10 mph), moderate effort swimming, general calisthenics,
table tennis, golf (pulling cart or carrying clubs), fishing (standing/casting),
leisurely canoeing (2.0-3.9 mph), painting (home repair), mowing lawn (power
mower), volleyball, softball, or working at a job that involved active cleaning
such as scrubbing floors and vacuuming? (PLEASE CIRCLE ONLY ONE CHOICE
WHICH BEST DESCRIBES YOUR ACTIVITY STYLE)
daily . . . . . . . . . . . . . . . . . . . .
4-6 times per week . . . . . . . . .
2-3 times per week . . . . . . . . .
one time per week . . . . . . . . . .
1-3 times per month . . . . . . . .
never . . . . . . . . . . . . . . . . . . .

1
2
3
4
5
6

If you practice any MODERATE activity, ON AVERAGE, state how many minutes do
you do MODERATE activity on a single time? (_)

P4.

If you have practiced the MOD ERA TE physical actrvrty style you described
above for more than one year, then specifically state how many years?
(
) YEARS
Please describe your MOD ERA TE activities:
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CURRENT PHYSICAL ACTIVITY QUESTIONNAIRE

DIRECTIONS: Please circle the number or mark the appropriate box to answer each
question. In some instances it will be necessary to fill in blanks with further
information.
P1.

DURING A TYPICAL WEEK IN THE LAST MONTH, HOW OFTEN DID YOU
PARTICIPATE IN VIGOROUS PHYSICAL ACTIVITIES such as, dance, basketball,
gymnastics, running, aerobics, or field hockey, briskly walking uphill or with a
load, fast or racing cycling ( > 10 mph), fast treading or crawl swimming, stair
ergometer, ski machine conditioning exercise, single tennis, racketball, fishing
in stream, rapidly canoeing ( > 4 mph), moving furniture, mowing lawn (hand
mower)? (PLEASE CIRCLE ONLY ONE CHOICE WHICH BEST DESCRIBES
YOUR CURRENT ACTIVITY STYLE)
daily . . . . . . . . . . . . . . . . . . . .
4-6 times per week . . . . . . . . .
2-3 times per week . . . . . . . . .
one time per week . . . . . . . . . .
1-3 times per month . . . . . . . .
never . . . . . . . . . . . . . . . . . . .

1
2
3
4
5
6

If you practice any VIGOROUS activity, ON AVERAGE, state how many minutes do
you do VIGOROUS activity on a single time? (_)
Please describe your VIGOROUS activities:
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DURING A TYPICAL WEEK IN THE LAST MONTH, HOW OFTEN DID YOU
PARTICIPATE IN MODERATE PHYSICAL ACTIVITIES such as briskly walking
(3-4 mph); Cycling for pleasure or transportation ( < 10 mph), moderate effort
swimming, general calisthenics, table tennis, golf (pulling cart or carrying
clubs), fishing (standing/casting), leisurely canoeing (2.0-3.9 mph), painting
(home repair), mowing lawn (power mower), volleyball, softball, or working at
a job that involved active cleaning such as scrubbing floors and vacuuming?
(PLEASE CIRCLE ONLY ONE CHOICE WHICH BEST DESCRIBES YOUR
CURRENT ACTIVITY STYLE)
daily . . . . . . . . . . . . . . . . . . . .
4-6 times per week . . . . . . . . .
2-3 times per week . . . . . . . . .
one time per week . . . . . . . . . .
1-3 times per month . . . . . . . .
never . . . . . . . . . . . . . . . . . . .

1
2
3
4
5
6

If you practice any MODERATE activity, ON AVERAGE, state how many minutes do
you do MODERATE activity on a single time?(_)

Please describe your MODERATE activities:
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AMERICAN HEART ASSOCIATION PHYSICAL ACTIVITY QUESTIONNAIRE
1995
Choose the column (A, B or C) that best describes your usual level of physical
activity. Rate your activity level:
Column A . . . . . . . . . 1
Between Column A and B?.
Column B . . . . . . . . . . 3
Between Column B and a+
Column C . . . . .
5

A
HIGHLY ACTIVE
My job requires very
hard physical labor (such
as digging or loading
heavy objects) at least
four hours a day
OR
I do vigorous activities
(jogging, cycling,
swimming, etc.) at least
three times per week for
30-60 minutes or more
OR
I do at least one hour of
moderate activity such
as brisk walking at least
four days a week

B
MODERATELY
ACTIVE
My job requires that
I walk, list, carry or
do other moderately
hard work for
several hours per
day (day care
worker, stock clerk
or busboy/waitress)
OR
I spend much of my
leisure time doing
moderate activities
(dancing, gardening,
walking or
housework)

c
INACTIVE
My job requires that I
sit at a desk most of
the day
AND
much of my leisure
time is spent in
sedentary activities
(watching TV,
reading, etc.)
AND
I seldom work up a
sweat and I cannot
walk fast without
having to stop to
catch my breath
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HEALTH HISTORY

The following questions are about your menstrual history:
1.

How old were you when you had your first menstrual period?
_ _ (Age)

2.

At what age, did your menstrual periods become regular, that is, you could usually predict about
when they would start?
___(Age)
_ _ _ Never became regular

3.

Did your periods become regular naturally, or because of taking birth control pills, or in some
other way?
Naturally . . . . . . . . . . . . . . . .
Birth control pill . . . . . . . . . . 2
Some other way . . . . . . . . . . . 3

4.

Please check the one response that best describes your menstrual cycles over the past 12 months:
!).
2).

3).
4).
5).
6).

5.

I menstruated over the past 12 months, and my periods were regular, for me
I was pregnant or breastfeeding during the past 12 months, and my periods were
infrequent or absent
I menstruated over the past 12 months, but my periods were irregular, or infrequent, or
different, for me
I did not menstruate over the past 3-11 months.
I did not menstruate over the past 12 months because I have gone through a natural, or
non-surgical menopause and therefore I no longer menstruate.
I did not menstruate over the past 12 months because I have had my uterus and/or both
ovaries removed, therefore. I no longer menstruate

In general, are or were, you able to predict. within a few days, when your next period would
begin? That is. were your menstrual periods regular'1
I don't know; I never paid attention to my period . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8
No. they were not generally regular . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . ....... 0
Y<!S, they were generally regular . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ...... .
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If yes, how often. on the average, did or do your menstrual periods come?
Every
days

Was there any time in your life when there were more than 40 days between the beginning of one
period and the beginning of the next, or when your periods stopped for at least six months (not
including when you were pregnant or breastfeeding)?
No . . . . . . . . . . . . . . 0
Yes . . . . . . . . . . . . .

7.

Have you ever had premenstrual syndrome?
No . . . . . . . . . . . . . . . . . . . . 0
Yes . . . . . . . . . . . . . . . . . · ·
Don't know . . . . . . . . . . . . . . 2

8.

Circle any of the members of your family listed below who ever suffered from perimenopausal
symptoms and describe their symptoms if you can?
No one . . . . . . . . . . . . . . . . .
Your mother . . . . . . . . . . . . .
Your sister . . . . . . . . . . . . . .
Your mother's mother .......
Your father's mother . . . . . . . .
Your mother's sisters . . . . . . .
Your father's sisters . . . . . . . .

0
2
3
4
5
6

Please describe

9.

Have you ever been pregnant?
No
yes
a.

............ 0

If yes, circle the number that represents the outcomes of each pregnancy and include the
number of times each occurred:
I =live birth
#
2=induced abortion
# _ _ __
3=miscarriage or spontaneous abortion
# _ _ _ __

142

APPENDIX F (cont.)

#
4=stillbirth
5=ectopic tubal pregnancy

#

6=other (specify) _ _ _ _ _ _ _ _ _ _ _ _ _ __

I 0.

#

-----

Have you ever taken oral contraceptives, or birth control pills for reasons other than regulating
your period?

No .......................... 0
Yes

....................... , .

The following questions are about your medical history:
Have you ever been told by a nurse or a doctor that you had any of the following conditions?
Circle each one you have had or currently have.

11.

I)

Drinking problem or alcoholism

2)

Angina/Chest pain

3)

Heart Attack

4)

High blood pressure/hypertension

5)

Stroke

6)

Tuberculosis

7)

Chronic bronchitis or emphysema

8)

Allergy

9)

Stomach ulcers

10)

Chronic colitis/Crohn · s disease

11)

Diabetes

12)

Kidney or renal disease

13)

Bladder problems

APPENDIX F (cont.)

14)

Liver disease/hepatitis

15)

Arthritis

16)

Osteoporosis

17)

Polycystic ovaries

18)

Anorexia Nervosa

19)

Infertility

20)

Endometriosis

21)

Abnormal pap smear

22)

Cancer

23)

Thyroid disease

24)

Other-specify

The following questions are about any medications you are taking now:
12.

Have you taken any of the following pills within the past year?
a.

Beta Carotene

b.

Vitamin A

Yes

No

c.

Vitamin B

Yes

No

d.

Vitamin C

Yes

No

e.

Vitamin E

Yes

No

f.

Iron

Yes

No

a

Multivitamins

Yes

No

~

Yes

No
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If you have taken any of the following within the past year, please list the name, the dose and the
frequency of each medication below and the date that you last took the medication.

13.

Please list any prescribed medications you regularly take:

14.

Please list any over the counter medications you routinely take:

15.

Please list any medications you have ever taken to relieve perimenopausal symptoms (For example,
Rejuvex):

The last question is about your smoking history:
16.

Which one of the following best describes you:
Never smoked . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0
Never smoked but live with a smoker . . . . . . . . . .
. ............ .
Have smoked for six month or longer but quit
................ 2
Currently smoke . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3
If you have ever smoked or are currently smoking, how many years have you smoked
_______ (yrs), and how many packages doidid you smoke a day ______ (pack/day).
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You did it !
Congratulations!
We appreciate all the time and thought you put into
answering these questions.
Please check that you didn't leave any questions
blank
Return this booklet in the attached self-addressed
stamped envelope as soon as possible
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IRB APPROVAL

LOYOLA UNIVERSITY INSTITUTIONAL REVIEW SOARD FOR THE PROTECTION OF
HUMAN SUBJECTS-MEDICAL CENTER
Li, Suling

LU NUMBER:

7424.00

The influence of regular physical activity on perimenopause.
Dear Investigator:
Attached is the full approval for your research project.
The date of full approval is 12/11/95.
This approval expires on 12/10/96 which is the date of the first scheduled
periodic review of a research activity.
The frequency of review of this research project will be l2 months.
You are approved to enroll 88 participants in your research project.
IF YOU WISH TO EXCEED THIS NUMBER YOU MUST PROVIDE WRITTEN JUSTIFICATION AND
SEEK THE PRIOR APPROVAL OF THE BOARD.
Please note that the Loyola Institutional Review Board for the Protection of
Human Subjects is appropriately constituted and has been granted Multiple
Projects Assurance Number M-1387 (effective 05/01/94 to 04}30/99).
Attached are an amendment report form, an adverse protocol reaction form,
a temporary protocol closure notice, request to resume protocol activity
after temporary closure and a permanent closure form.
These forms are to be
used when reporting actions to the IRB.
The blank forms may be xeroxed
and used for subsequent amendments, adverse protocol reactions and
temporary closure notification for THIS PROJECT ONLY.

Thank you.
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,YOLA UNIVERSITY INSTITUTIONAL REVIEW BOARD FOR THE PROTECTION OF HUMAN
HUMAN SUBJECTS (MEDICAL CENTER)
PROTOCOL AMENDMENTS/REVISIONS
REQUIRING IRB ACTION
NOTIFICATION OF FULL APPROVAL OF AMENDMENT
7424.00

LU NUMBER:
AMEND 1 :

INVESTIGATOR:

Li

, Suling

See PI letter dated 12/13/95.
Further considerations now suggest that 500 women will be needed
to achieve statistical significance.

1.
2.
J.
4.

DATE OF REVIEW: 12/20/95
SUBSTANTIVE (SUBS) OR ADMINISTRATIVE (ADMIN) CHANGE: ADMIN
EXPEDITED (ER) OR FULL BOARD (FB) REVIEW: FB
EFFECT OF AMENDMENT ON RISK TO THE PATIENT
(INCrease, DECrease, NoChange): NC
5. CHANGES NECESSARY TO THE INFORMED CONSENT DOCUMENT (Y/N): N
(12/20/95- 7424112095]
6. WILL THE BOARD REQUIRE THAT PAST OR CURRENT PARTICIPANTS BE APPRISED
OF THE NEW INFORMATION (Y/N) : N
COMMENTS: None.
ACTION (APProve, Conditional Approval, Table, DISapprove):
IF PREVIOUSLY TABLED:
DATE OF REREVIEW:

APP

ACTION OF REREVIEW:

DATE OF APPROVAL:
KENNETH CRAIG MicETICH, M.D.
CHAIRMAN, INSTITUTIONAL REVIEW BOA.al) (MEDICAL CENTER)

12/20/95
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Date
Subject's Name
Street Address
City, State Zip code
Dear Ms.
In 1992, you participated in the Women Take Heart Study at St. James Medical
Center, Chicago Heights. I am presently a doctoral student at Loyola University
Medical Center and am now working with Dr. Al-Hani, the principal
investigator, and Dr. Holm, a member of the medical advisory committee for
Women Take Heart, to extend the study by examining the relationships
between physical activity and health during perimenopause/menopause.
Perimenopause, the period before and after menopause, is a time when women
experience changes in their menstruation pattern, for example, having a longer
or shorter interval between periods or excessive or scanty bleeding, or no
period for three to eleven months. Many women find the symptoms associated
with these changes to be bothersome or distressing. We believe it is important
to study what can be done to relieve or prevent distressful symptoms.
Therefore, we would like to invite you to participate. If you agree, please
complete the enclosed questionnaires which should take approximately 25
minutes.
This research project is also part of the requirement for my Ph.D. degree in the
Graduate School of Nursing, Loyola University of Chicago. Dr. Al-Hani and Dr.
Holm are on my research committee.
Your participation is voluntary. All responses and identifying information will
be kept strictly confidential. Your completion and return of the questionnaires
will be an indication of your consent and willingness to participate in this study.
Some of the participants will be asked to complete the questionnaires again at
a later date.
The completed questionnaire can be faxed to me at (708) 327-9183, or you
can mail it to me at Loyola University Medical Center, 2160 South First
Avenue, Maywood, Illinois, 60153.
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If you have any questions, I can be reached at (708) 216-9577 on most week
days between 9AM to 5PM, Chicago time or leave a message on my voice mail
(708) 327-9173. Dr. Holm, the supervising nurse scientist for this project can
be reached at (708) 216-3831 at the Department of Medical-Surgical Nursing
at Loyola University Medical Center.
If you have any questions concerning your rights as a research participant,
please contact Kenneth C. Micetich, M.D., Chairman, Institutional Review
Board for the Protection of Human Subjects, Loyola University Medical Center,
708-21 6-4608.
We sincerely appreciate your participation in this study. The information we
learn will help us to provide better care to our midlife women who are going
through perimenopause/menopause.
Thank you for your time
Sincerely,

Suling Li RN MSN
Ph.D candidate
cc:

Dr. Al-Hani
Dr. Holm
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Subject's Name
Street Address
City, State Zip code
Dear Ms.
Thank you for completing the questionnaire for the Women's Health study. As
directed by my research committee (Dr. Al-Hani and Dr. Holm), it is necessary
to have you complete the same questionnaire again to assess consistency of
women's responses.
Please complete the enclosed questionnaire and return it to me in the
addressed, stamped envelope within two weeks. Again, your participation is
voluntary. If you have any questions, please do not hesitate to call. I can be
reached at (708) 216-9101 on most week days between 9AM to 5PM, Chicago
time or leave a message on my voice mail (708) 327-9173. Dr. Holm, the
supervising nurse scientist for this project can be reached at (708) 216-3831
at the Department of Medical-Surgical Nursing at Loyola University Medical
Center.

Thank you for your time

Sincerely

Suling Li RN MSN
Ph.D candidate

cc:

Dr. Al-Hani
Dr. Holm
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Date
Subject's Name
Street Address
City, State Zip code
Dear Ms.
When women reach a certain age, they go through a time when they experience changes in
their menstruation pattern, for example, having a longer or shorter interval between periods or
excessive or scanty bleeding. Many women find the symptoms associated with these changes
to be bothersome or distressing. I believe it is important to study what can be done to relieve
or prevent distressful symptoms. Therefore, if you are: experiencing changes in your menstrual
pattern; aged 40 and above; not on hormone replacement therapy or oral contraceptives within
the past five years; and have no history of hysterectomy or bilateral oophorectomy, I invite you
to participate in a study of how regular physical activity affects this time of transition. Taking
part in the study involves filling out a questionnaire booklet which takes about 20 minutes. The
booklet includes a Women's Health Assessment Scale, Physical Activity Questionnaire, a Health
History and a Demographic Questionnaire.
You will find the booklet enclosed with this letter. If you agree to participate in this study,
please answer all of the questions to the best of your ability. Your name is not needed
anywhere on the booklet, so your answers will be confidential. If you have any questions,
please call me at (708) 327-9173 or (708) 216-9101.
I would appreciate it if you could return the questionnaire booklet within two weeks after
receiving it. The completed booklet can be mailed to me at Loyola University Chicago, Medical
Center, School of Nursing, Building 105, Room 2840.
I sincerely appreciate your participation in this study. The information I learn will help us to
provide better care to our midlife women who are going through perimenopause/menopause.

Sincerely

Suling Li, RN, MSN
PhD Candidate
School of Nursing
Bldg 105 - RM 2840
LUMC
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